KR100226142B1 - Benzophenone derivatives, UV absorbers and external skin preparations containing them - Google Patents
Benzophenone derivatives, UV absorbers and external skin preparations containing them Download PDFInfo
- Publication number
- KR100226142B1 KR100226142B1 KR1019920019299A KR920019299A KR100226142B1 KR 100226142 B1 KR100226142 B1 KR 100226142B1 KR 1019920019299 A KR1019920019299 A KR 1019920019299A KR 920019299 A KR920019299 A KR 920019299A KR 100226142 B1 KR100226142 B1 KR 100226142B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- benzophenone
- general formula
- hydroxyl group
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
- C07C49/784—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic with all keto groups bound to a non-condensed ring
- C07C49/786—Benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 하기 일반식(1)에서 나타낸 벤조페논유도체에 관한 것으로서,The present invention relates to a benzophenone derivative represented by the following general formula (1),
상기 일반식(1)중, A는 당 또는 당알콜에서 1개의 수산기를 제외한 잔기이고, B는 하기의 일반식(2)에서 나타낸 벤조페논기를 나타낸다.In said General formula (1), A is a residue remove | excluding one hydroxyl group from sugar or sugar alcohol, B represents the benzophenone group shown by following General formula (2).
(단, R1, R2는 수소 또는 수산기 R3∼R10은 수소 또는 수산기, 알콕시기 또는 상기 결합제 C로 나타내고 한 개이상이 결합제 C이다.(Wherein R 1 , R 2 are hydrogen or hydroxyl groups R 3 to R 10 are hydrogen or hydroxyl groups, alkoxy groups or the above-mentioned binder C and at least one is binder C).
알콕시기의 경우 바람직한 것은 탄소수 1∼4이며, C는 -O-R-(O는 산소, R은 지방사슬, 바람직하게는 전탄소수 1∼4를 나타낸다) 또는 글리세린 1몰에 상당하고 이중 하나의 수산기를 A와, 다른 하나의 수산기를 B와 결합시킨다.)In the case of an alkoxy group, preferred is 1 to 4 carbon atoms, C is -OR- (O is oxygen, R represents an aliphatic chain, preferably 1 to 4 carbon atoms) or 1 mole of glycerin, and one hydroxyl group Combine A with the other hydroxyl with B.)
본 발명에 관련된 벤조페논유도체에 의하면 뛰어난 자외선흡수능력 및 극성용매상용성을 가지며, 이것을 배합한 피부외용제는 극성기제에 대해서도 배합 가능하고 뛰어난 사용성을 발휘할 수 있다.According to the benzophenone derivative according to the present invention, it has excellent ultraviolet absorbing ability and polar solvent compatibility, and the external preparation for skin can be blended with the polar base and can exhibit excellent usability.
Description
제1도는 본 발명의 한실시예에 관련된 1-(4-벤조일페닐) 글리세롤멀티톨루에테르의 적외흡수 스펙트럼챠트도.1 is an infrared absorption spectral chart of 1- (4-benzoylphenyl) glycerolmultitoluether related to one embodiment of the present invention.
제2도는 본 발명의 한실시예에 관련된 1-(4-벤조일페닐) 글리세롤멀티톨루에테르의13C-NMR 스펙트럼챠트도.2 is a 13 C-NMR spectrum chart of 1- (4-benzoylphenyl) glycerolmultitoluether related to one embodiment of the present invention.
제3도는 본 발명의 한실시예에 관련된 1-(4-벤조일페닐) 글리세롤멀티톨루에테르의1H-NMR 스펙트럼챠트도.3 is a 1 H-NMR spectrum chart of 1- (4-benzoylphenyl) glycerol multitoluether according to one embodiment of the present invention.
제4도는 본 발명의 한실시예에 관련된 1-(4-벤조일페닐) 글리세롤멀티톨루에테르의 자외흡수 스펙트럼챠트도.4 is an ultraviolet absorption spectrum chart of 1- (4-benzoylphenyl) glycerol multitoluether according to one embodiment of the present invention.
제5도는 본 발명의 한실시예에 관련된 1-(4-벤조일-3-히드록시페닐) 글리세롤멀티톨루에테르의 적외흡수 스펙트럼챠트도.5 is an infrared absorption spectrum chart of 1- (4-benzoyl-3-hydroxyphenyl) glycerol multitoluether related to one embodiment of the present invention.
제6도는 본 발명의 한실시예에 관련된 1-(4-벤조일-3-히드록시페닐) 글리세롤멀티톨루에테르의13C-NMR 스펙트럼챠트도.6 is a 13 C-NMR spectrum chart of 1- (4-benzoyl-3-hydroxyphenyl) glycerolmultitoluether related to one embodiment of the present invention.
제7도는 본 발명의 한실시예에 관련된 1-(4-벤조일-3-히드록시페닐) 글리세롤멀티톨루에테르의1H-NMR 스펙트럼챠트도.7 is a 1 H-NMR spectrum chart of 1- (4-benzoyl-3-hydroxyphenyl) glycerol multitoluether according to one embodiment of the present invention.
제8도는 본 발명의 한실시예에 관련된 1-(4-벤조일-3-히드록시페닐) 글리세롤멀티톨루에테르의 자외흡수 스펙트럼챠트도.8 is an ultraviolet absorption spectrum chart of 1- (4-benzoyl-3-hydroxyphenyl) glycerol multitoluether according to one embodiment of the present invention.
제9도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-말토실옥시에톡시) 벤조페논의 적외흡수 스펙트럼챠트도.9 is an infrared absorption spectrum chart of 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제10도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-말토실옥시에톡시) 벤조페논의13C-NMR 스펙트럼챠트도.10 is a 13 C-NMR spectrum chart of 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제11도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-말토실옥시에톡시) 벤조페논의1H-NMR 스펙트럼챠트도.FIG. 11 is a 1 H-NMR spectrum chart of 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone according to one embodiment of the present invention. FIG.
제12도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-말토실옥시에톡시) 벤조페논의 자외흡수 스펙트럼챠트도.12 is an ultraviolet absorption spectrum chart of 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제13도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-글루코실옥시에톡시) 벤조페논의 적외흡수 스펙트럼챠트도.13 is an infrared absorption spectrum chart of 2-hydroxy4- (2-glucosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제14도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-글루코실옥시에톡시) 벤조페논의13C-NMR 스펙트럼챠트도.14 is a 13 C-NMR spectrum chart of 2-hydroxy4- (2-glucosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제15도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-글루코실옥시에톡시) 벤조페논의1H-NMR 스펙트럼챠트도.Fig. 15 is a 1 H-NMR spectrum chart of 2-hydroxy4- (2-glucosyloxyethoxy) benzophenone according to one embodiment of the present invention.
제16도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-글루코실옥시에톡시) 벤조페논의 자외흡수 스펙트럼챠트도.FIG. 16 is an ultraviolet absorption spectrum chart of 2-hydroxy4- (2-glucosyloxyethoxy) benzophenone according to one embodiment of the present invention. FIG.
제17도는 본 발명의 한실시예에 관련된 2-히드록시4-(2-말토실옥시프로필옥시) 벤조페논의 적외흡수 스펙트럼챠트도.17 is an infrared absorption spectrum chart of 2-hydroxy4- (2-maltosyloxypropyloxy) benzophenone according to one embodiment of the present invention.
제18도는 본 발명의 한실시예에 관련된 3-히드록시4-(2-말토실옥시프로필옥시) 벤조페논의13C-NMR 스펙트럼챠트도.FIG. 18 is a 13 C-NMR spectrum chart of 3-hydroxy4- (2-maltosyloxypropyloxy) benzophenone according to one embodiment of the present invention. FIG.
제19도는 본 발명의 한실시예에 관련된 3-히드록시4-(2-말토실옥시프로필옥시) 벤조페논의1H-NMR 스펙트럼챠트도.Fig. 19 is a 1 H-NMR spectrum chart of 3-hydroxy4- (2-maltosyloxypropyloxy) benzophenone according to one embodiment of the present invention.
제20도는 본 발명의 한실시예에 관련된 3-히드록시4-(2-글루코실옥시프로필옥시) 벤조페논의 자외흡수 스펙트럼챠트도이다.20 is an ultraviolet absorption spectral chart of 3-hydroxy4- (2-glucosyloxypropyloxy) benzophenone according to one embodiment of the present invention.
본 발명은 벤조페논유도체, 자외선흡수제 및 피부외용제에 관한 것으로, 특히 수상에 대한 용해성이 높은 벤조페논유도체와 이를 사용한 자외선흡수제 및 피부외용제에 관한 것이다.The present invention relates to a benzophenone derivative, an ultraviolet absorber and an external preparation for skin, and more particularly, to a benzophenone derivative having high solubility in aqueous phase, an ultraviolet absorber and an external preparation for skin using the same.
통상 인체가 받는 자외선은 그 대부분이 태양광선에서 유래한다.Usually, most of the ultraviolet rays received by the human body are derived from sunlight.
태양광선에 포함된 자외선은 피부과학적으로는 400㎚∼320㎚의 장파장자외선(UV-A), 320㎚∼290㎚의 중파장자외선(UV-B), 290㎚이하의 단파장자외선(UV-C)으로 분류된다.Ultraviolet rays contained in sunlight are dermatologically long-wavelength ultraviolet rays (UV-A) of 400 nm to 320 nm, medium-wavelength ultraviolet rays (UV-B) of 320 nm to 290 nm, and short wavelength ultraviolet rays of 290 nm or less (UV-C). Are classified as).
이중에서 290㎚이하 파장의 자외선은 오존층에 의해 흡수되고 지표에 도달되지 않는다.Among them, ultraviolet rays having a wavelength below 290 nm are absorbed by the ozone layer and do not reach the surface.
지표에 도달된 자외선은 인간의 피부에 여러 가지 영향을 미친다.Ultraviolet rays that reach the surface have several effects on human skin.
지상까지 도달된 자외선중, UV-A는 피부의 갈색화를 야기하고 피부의 탄력성 저하 및 주름의 발생을 촉진시켜 급격한 노화를 초래한다.Among the ultraviolet rays reached to the ground, UV-A causes browning of the skin and promotes the decrease of elasticity of the skin and the occurrence of wrinkles, leading to rapid aging.
또한 홍반반응의 개시를 촉진시키며 어떤류의 환자에 대해서는 이 반응을 증가시켜 더욱 광독성 혹은 광알레르기반응의 원인으로도 될 수 있다.It also promotes the onset of erythema reactions and, in some types of patients, increases the response, which may be the cause of more phototoxic or allergic reactions.
한편 UV-B 또한 피부의 홍반이나 수포를 형성하고 멜라닌 형성이 항진되며 색소침착을 발생시키는 등의 변화를 초래한다.On the other hand, UV-B also causes erythema or blisters on the skin, melanin formation is enhanced, and pigmentation occurs.
이 때문에 피부의 노화를 막고 기미, 주근깨의 발생과 악영향을 막을 수 있는데다 자외선으로부터 피부를 보호하는 일이 중요해서 각종 자외선흡수제가 개발되어 왔다.For this reason, it is possible to prevent the aging of the skin and to prevent the occurrence and adverse effects of blemishes and freckles, and to protect the skin from ultraviolet rays, various ultraviolet absorbers have been developed.
기존의 자외선흡수제로서는 PABA유도체, 계피산유도체, 살리실산유도체, 벤조페논유도체, 유로카닌유도체, 캄파유도체 및 복소환유도체등이 이용되어 왔다.As a conventional ultraviolet absorber, PABA derivatives, cinnamic acid derivatives, salicylic acid derivatives, benzophenone derivatives, urocanine derivatives, camphor derivatives and heterocyclic derivatives have been used.
그리고 이들 자외선흡수제는 통상 화장료 혹은 의약부외품등의 피부외용제에 배합되어 왔지만 외용제기제에는 저분자량의 디메틸실록산계 기제가 널리 이용되고 있다.These ultraviolet absorbers have been commonly formulated into external skin preparations such as cosmetics or quasi-drugs, but low molecular weight dimethylsiloxane bases are widely used in external preparations.
즉 무엇보다 자주 자외선차단용 화장품을 사용하는 것이 여름이므로 내한성, 내수성등의 관점에서 유성기제가 범용되고 이결과 자외선흡수제로서 사용되어 온 것은 유용성의 것이 대부분이였다.In other words, the most frequent use of sunscreen cosmetics in summer is the oil-based base in terms of cold resistance, water resistance, etc. As a result, it has been mostly useful as a UV absorber.
그러나 최근에는 일상생활에서 받는 자외선의 영향에 있어서도 문제가 되고 있고 통상의 스킨케어에 있어서도 자외선차단용 화장품이 요구되고 있다.Recently, however, there has been a problem in the influence of ultraviolet rays received in daily life, and sunscreen cosmetics are also required in normal skin care.
따라서 화장수등의 수용계의 피부관리제품에서도 다량으로 배합할 수 있는 점, 보다 고자외선 흡수효과를 가지는 외용제를 처방하는데도 전체에 다량의 자외선흡수제를 배합할 수 있는 편이 좋기 때문에 유상뿐만 아니라 수상에서도 자외선흡수제를 배합하는 것이 바람직하다는 것 등으로부터 수용성으로 자외선을 흡수하는 물질의 개발이 크게 요구되고 있다.Therefore, it can be blended in a large amount in skin care products such as water lotion, and it is better to mix a large amount of UV absorber to the whole even when prescribing an external agent having higher UV absorption effect. Since it is preferable to mix | blend an absorber, the development of the substance which absorbs ultraviolet-ray by water solubility is calculated | required greatly.
그리고 종래의 자외선흡수제는 전술한 바와 같이 그 대부분이 유용성으로 수용성이 적고 처방이 제한되어 왔다.As described above, most of the conventional ultraviolet absorbers have low water solubility due to their usefulness and limited prescription.
수용성자외선흡수제로서는 단지 2-히드록시-4-메톡시-5-설폭소늄벤조페논나트륨 염이 알려져 있을뿐 이것은 염이기 때문에 처방계의 pH에 영향을 미치는 과제가 있었다.As the water-soluble ultraviolet absorber, only 2-hydroxy-4-methoxy-5-suloxoniumbenzophenone sodium salt is known, and since it is a salt, there has been a problem affecting the pH of the prescription system.
본 발명은 상기 종래 기술의 과제를 감안해 이루어진 것으로 그 목적은 우수한 자외선 흡수성을 가지는 한편 수용성인 물질 및 그것을 배합한 피부외용제를 제공하는데 있다.This invention is made | formed in view of the subject of the said prior art, The objective is to provide the substance which has the outstanding ultraviolet absorption, water-soluble, and the skin external preparation which mix | blended it.
상기 목적을 달성하기 위해서 본 발명자들이 예의검토한 결과 벤조페논유도체가 뛰어난 자외선흡수성 및 극성 용매상용성을 가지는 것을 발견하고, 본 발명을 완성하는데 이르렀다.As a result of careful examination by the present inventors in order to achieve the said objective, they discovered that a benzophenone derivative has the outstanding ultraviolet absorption and polar solvent compatibility, and came to complete this invention.
즉 본 출원인의 제1항의 벤조페논유도체는 하기 일반식(1)로 나타낸다.That is, the benzophenone derivative of Claim 1 of this applicant is represented by following General formula (1).
(상기 일반식(1)에서, A는 당 또는 당알콜에서 1개 이상의 수산기를 제거한 잔기, B는 하기 일반식(2)로 나타낸 벤조페논기이며,(In the general formula (1), A is a residue obtained by removing one or more hydroxyl groups from a sugar or sugar alcohol, B is a benzophenone group represented by the following general formula (2),
(상기 일반식(2)에서, R1∼R10은 수소 또는 수산기, 또는 C1∼C4의 알콕시기 또는 상기 결합제 C로 나타내고, 한 개가 결합제 C이다)(In the general formula (2), R 1 ~R 10 denotes hydrogen or a hydroxyl group, or alkoxy group or a binder C of the C 1 ~C 4, is a dog binder C)
C는 -O-R-O-(O는 산소, R은 C1-4지방사슬임), 또는 글리세린 1몰에 상당하고, 이중 하나의 수산기를 A와, 다른 하나의 수산기를 B와 결합하며, n은 1 이상의 정수이다)C corresponds to -ORO- (O is oxygen, R is C 1-4 fatty chain), or 1 mole of glycerin, of which one hydroxyl group is bonded to A and the other hydroxyl group to B, and n is 1 Is an integer greater than or equal to
제2항의 기재의 자외선흡수제는 상기 일반식(1)의 벤조페논유도체를 1종 또는 2종이상 포함한 것을 특징으로 한다.The ultraviolet absorber of Claim 2 is characterized by including 1 type (s) or 2 or more types of benzophenone derivatives of the said General formula (1).
제3항 기재의 피부외용제는 상기 일반식(1)의 벤조페논유도체를 1종 또는 2종이상 포함한 것을 특징으로 한다.The external preparation for skin according to claim 3 is characterized by comprising one or two or more benzophenone derivatives of the general formula (1).
또한 본 출원의 제4항 기재의 벤조페논유도체는 하기 일반식(3)으로 나타낸다.In addition, the benzophenone derivative of Claim 4 of this application is represented by following General formula (3).
(상기 일반식(3)에서, A는 당 또는 당알콜에서 1개 이상의 수산기를 제거한 잔기, C는 글리세린 1몰에 상당하고, 이중 하나의 수산기를 A와, 다른 하나의 수산기를 B와 결합하며, B는 하기 일반식(4)로 나타낸 벤조페논기이며,(In the formula (3), A is a residue obtained by removing one or more hydroxyl groups from a sugar or sugar alcohol, C is equivalent to 1 mole of glycerin, and one of the hydroxyl groups is bonded to A and the other hydroxyl group to B, B is a benzophenone group represented by the following general formula (4),
(상기 일반식(4)에서, R1∼R9중 하나는 C이고, 다른 것은 수소 또는 수산기, 알킬기, 알콕실기이다)(In the general formula (4), one of R 1 to R 9 is C, and the other is hydrogen or a hydroxyl group, an alkyl group, an alkoxyl group.)
n은 1이상의 정수이다)n is an integer greater than or equal to 1)
제5항 기재의 자외선흡수제는 상기 일반식(3)의 벤조페논유도체를 1종 또는 2종이상 포함한 것을 특징으로 한다.The ultraviolet absorber of Claim 5 is characterized by including 1 type (s) or 2 or more types of benzophenone derivatives of the said General formula (3).
제6항 기재의 피부외용제는 상기 일반식(3)의 벤조페논유도체를 1종 또는 2종이상 포함한 것을 특징으로 한다.The skin external preparation according to claim 6 is characterized in that it contains one or two or more benzophenone derivatives of the general formula (3).
상기 일반식(3)에 있어서 A는 당 또는 당알콜의 잔기이고, 당의 구체예로서는 글루코스, 갈락토스, 크실로스, 프룩토스, 알토로스, 타로스, 만노스, 아라비노스, 이도스, 릭키소스, 리보오스, 알로오스 등의 단당류 및 그 혼합물, 또는 말토스, 이소말토스, 락토스, 크실로비오스, 켄티오비오스, 코디오비오스, 셀로비오스, 소호로스, 니게로스, 수크로스, 메리비오스, 라미나리비오스, 루티노스 등의 이당류 및 그 혼합물, 또는 말토트리오스 등의 삼당류 및 그 혼합물 또는 그 이상의 다당류 및 그 혼합물 또한 이들의 단당, 이당 그 이상의 다당혼합물을 사용하는 것도 가능하다. 당알콜의 구체예로서는 멀티톨, 솔비톨, 만니톨, 가리쿠치톨, 글리시톨, 이노시톨, 멀티트리올 등의 당알콜 및 그 혼합물 또는 그 이상의 다당알콜 및 그 혼합물을 들수 있고, 또는 이들의 당알콜의 혼합물을 사용할 수 있다.In Formula (3), A is a residue of sugar or sugar alcohol, and specific examples of sugar include glucose, galactose, xylose, fructose, altorose, talos, mannose, arabinose, idose, rickisose, ribose and allose. Monosaccharides and mixtures thereof, or maltose, isomaltose, lactose, xylobiose, kenthiobiose, cordiobis, cellobiose, sohorose, nigerose, sucrose, merribiose, laminaribiose, lutinos It is also possible to use disaccharides such as disaccharides and mixtures thereof, or trisaccharides such as maltotriose and mixtures thereof, or more polysaccharides and mixtures thereof, and also monosaccharides thereof, and polysaccharide mixtures thereof. Specific examples of the sugar alcohols include sugar alcohols such as multitol, sorbitol, mannitol, garicuccitol, glycitol, inositol, multitriol, and mixtures thereof, or polysaccharide alcohols and mixtures thereof, or mixtures of sugar alcohols thereof. Can be.
또한 이들의 단당, 이당, 삼당 그 이상의 다당, 당알콜의 혼합물을 사용해도 같은 작용을 얻을 수 있다.The same effect can also be obtained by using a mixture of these monosaccharides, disaccharides, trisaccharides and more polysaccharides and sugar alcohols.
벤조페논기 B를 나타내는 일반식(4)에서 R1∼R4는 수소 또는 수산기, 알킬기 또는 알콕실기 또는 C와의 결합기를 나타낸다.In General Formula (4) representing the benzophenone group B, R 1 to R 4 represent hydrogen or a hydroxyl group, an alkyl group or an alkoxyl group, or a bonding group with C.
알킬기, 알콕실기의 경우 지방사슬은 직쇄알킬기, 분기알킬기, 불포화알킬기, 시클로알킬기 어느 것이라도 좋고, 지방사슬의 구체예로서는 메틸기, 에틸기, 아세티레닐기, 프로필기, 이소프로필기, 프로페닐기, 부틸기, 이소부틸기, t-부틸기, 부테닐기 등을 들 수 있다.In the case of an alkyl group or an alkoxyl group, the fatty chain may be a straight chain alkyl group, a branched alkyl group, an unsaturated alkyl group or a cycloalkyl group. Specific examples of the aliphatic chain include a methyl group, an ethyl group, an acetylenyl group, a propyl group, an isopropyl group, a propenyl group and a butyl group. , Isobutyl group, t-butyl group, butenyl group and the like.
모두 다 자외선흡수파장에 현저한 차이는 없지만 공업성 등에서 특히 메틸기, 에틸기가 바람직하다.Although there is no significant difference in the ultraviolet absorption wavelength in all, methyl group and ethyl group are preferable especially from industrial viewpoint.
C는 글리세린 1몰에 상당하는 글리세린기이고, 어떠한 결합부가에도 관계치 않는다.C is a glycerin group which is equivalent to 1 mole of glycerin, regardless of any bonding portion.
n은 정수를 나타내고, 수용성의 면에서 바람직한 것은 1∼3을 나타낸다.n represents an integer and 1 to 3 are preferable in terms of water solubility.
상기 벤조페논유도체는 고체 또는 시럽상태에서 안전성, 안전성이 극히 우수하기 때문에 염료와 잉크, 플라스틱, 코팅제, 화학섬유 등의 화학제품 등에 배합할 수 있는 이외 의약품, 의약부외품, 화장료 및 세정료의 성분으로서 배합될 수 있다.Since the benzophenone derivative is extremely safe and stable in a solid or syrup state, the benzophenone derivative can be blended with chemicals such as dyes, inks, plastics, coatings, and chemical fibers, and as a component of pharmaceuticals, quasi-drugs, cosmetics, and cleaning agents. Can be combined.
또한, 보습성을 가진다는 특성이 있다.In addition, there is a property of having moisture retention.
일반식(3)의 벤조페논유도체는 예를 들면 일반식(5)에서 나타낸 히드록시벤조페논을 글리시딜화하고 얻어진 일반식(6)에서 나타난 글리시딜옥시벤조페논을 당과 당알콜과 특원소 61-180989호에 기재된 방법등으로 반응시킴으로서 제조할 수 있다.The benzophenone derivatives of the general formula (3) are glycidylated hydroxybenzophenones represented by the general formula (5), and the glycidyloxybenzophenones represented by the general formula (6) are obtained by sugar, sugar alcohol and special elements. It can manufacture by reacting by the method of 61-180989.
예를 들면 다음과 같이 합성할 수 있다.For example, it can synthesize as follows.
일반식(6)에 나타낸 화합물은 일반식(5)으로 나타낸 화합물을 산드라등의 방법 {S.R.Sandler, F.R.Berg.J.Appl.Polymer.Soc.9,3707(1965)}과 로바트등의 방법{Tetrhedorn,35,2169∼2172(1979)}에 의해 반응시킴으로서 합성할 수 있다.As the compound represented by the general formula (6), the compound represented by the general formula (5) may be obtained by the method of Sandra et al. {SRSandler, FRBerg.J.Appl.Polymer.Soc. 9,3707 (1965)} and the method of Lobart. It can synthesize | combine by making it react by {Tetrhedorn, 35,2169-2172 (1979)}.
즉 디메틸설폭사이드, 디메틸포름아미드, 디오키산, 디메틸아세트아미드, N-메틸피롤리돈, N-아세틸몰포린, N-메틸호박산아미드등의 비수계용매에 용해 혹은 현탁하든가 아세톤수계용매로 용해 혹은 현탁하든가 또는 무용매로 에피크로르히드린과 촉매하에서 90∼130℃로 교반하고 이때 반응은 질소나 아르곤등의 기류하에서 실시해도 좋고 일반식(5)에 나타낸 화합물은 단독 또는 2종이상을 병용해도 좋다.That is, it is dissolved or suspended in non-aqueous solvents such as dimethyl sulfoxide, dimethylformamide, diocylic acid, dimethylacetamide, N-methylpyrrolidone, N-acetylmorpholine, and N-methyl amber acid amide, or dissolved in an acetone aqueous solvent. Suspended or stirred with epichlorohydrin at 90-130 ° C. under a catalyst with no solvent, and the reaction may be carried out under a stream of nitrogen or argon, or the compound represented by the general formula (5) alone or in combination of two or more thereof. good.
이때에 사용되는 촉매는 BF3·Et2O, 삼산화알미늄등의 루이스산촉매, P-톨루엔설폰산, 헤테로폴리인산, 염산, 황산등의 산촉매, 수산화나트륨, 수산화칼륨, 탄산칼륨, 탄산나트륨, 수산화나트륨, 나트륨알콜레이트등의 알칼리, N-메틸벤질아민등의 아민류등을 들 수 있다.The catalyst used at this time is a Lewis acid catalyst such as BF 3 · Et 2 O, aluminum trioxide, P-toluenesulfonic acid, heteropolyphosphoric acid, hydrochloric acid, acid catalysts such as sulfuric acid, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, sodium hydroxide, Amine, such as alkali, such as sodium alcoholate, and N-methylbenzylamine, etc. are mentioned.
일반식(3)에서 나타낸 화합물은 얻어진 일반식(4)에서 나타낸 화합물을 당과 당알콜과 특원소 61-180989호등에 기재된 방법등으로 반응시키는 방법등에 의해 제조할 수 있다.The compound shown by General formula (3) can be manufactured by the method etc. which make the compound shown by General formula (4) obtained by reaction with sugar, a sugar alcohol, the method of No. 61-180989, etc. are mentioned.
예를 들면 다음 방법으로 합성할 수 있다.For example, it can synthesize | combine by the following method.
당과 당알콜을 디메틸설폰사이드, 디메틸포름아미드, 디옥키산, 디메틸아세트아미드, N-메틸피롤리돈, N-아세틸몰포린, N-메틸호박산아미드등의 비수계용매에 용해 혹은 현탁하고 일반식(6)에 나타낸 화합물과 촉매하에서 90∼130℃로 교반하여 이때 반응을 질소와 아르곤등의 기류하에서 사용해도 좋고 일반식(6)에 나타낸 화합물은 단독 또는 2종이상을 병용해도 좋다.Sugars and sugar alcohols are dissolved or suspended in non-aqueous solvents such as dimethylsulfoxide, dimethylformamide, dioxic acid, dimethylacetamide, N-methylpyrrolidone, N-acetylmorpholine, and N-methyl zucchinamide. It stirred at 90-130 degreeC under the compound and catalyst which were shown in 6), At this time, reaction may be used under airflow, such as nitrogen and argon, and the compound shown by General formula (6) may be used individually or in combination of 2 or more types.
이때에 사용되는 촉매는 p-톨루엔설폰산, 헤테로폴리인산, 염산, 황산등의 산촉매, 수산화나트륨, 수산화칼륨, 탄산칼륨, 탄산나트륨, 수산화나트륨, 나트륨알콜레이트등의 알칼리, 염화암모늄, 염화나트륨등의 염, N-메틸벤질아민등의 아민류등을 들 수 있다.The catalyst used at this time is acid catalysts such as p-toluenesulfonic acid, heteropolyphosphoric acid, hydrochloric acid, sulfuric acid, sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate, sodium hydroxide, salts such as sodium alcohol, salts such as ammonium chloride and sodium chloride And amines such as N-methylbenzylamine.
이 반응에 사용되는 당 및 당알콜과 일반식(6)에 나타낸 화합물의 몰비는 예를들면 모노에테르를 주생성물로서 얻고자할 경우에는 1 : 1 ∼ 3 : 1 이 바람직하고, 2 : 1 ∼ 3 : 1 이 더욱 바람직하다.As for the molar ratio of the sugar and sugar alcohol used for this reaction, and the compound shown in General formula (6), for example, when it is going to obtain monoether as a main product, 1: 1-3: 1 are preferable, and 2: 1-3 : 1 is more preferable.
당 및 당알콜과 일반식(6)에 나타낸 화합물의 몰비가 이범위를 벗어날 경우, 즉 당 및 당알콜이 적으면 테트라에테르등의 불순물을 발생하기 쉽고, 너무 많으면 당과 당알콜이 다량으로 남아 다음의 정제에 지장을 초래하기 때문에 바람직하지 않다.When the molar ratio of sugars and sugar alcohols to the compound represented by the general formula (6) is out of this range, that is, if the sugar and sugar alcohols are small, impurities such as tetraether are likely to be generated. It is not preferable because it causes trouble.
촉매로 산과 알칼리를 사용한 경우, 일반식(6)에서 나타낸 화합물이 모두 소비된 후에 반응계의 촉매를 중화할 목적으로 초산, 염산, 황산, 인산등의 산, 수산화나트륨, 수산화칼륨등의 알칼리를 첨가했다.When acids and alkalis are used as catalysts, after all of the compounds represented by the general formula (6) are consumed, an acid such as acetic acid, hydrochloric acid, sulfuric acid, phosphoric acid, alkalis such as sodium hydroxide and potassium hydroxide is added for the purpose of neutralizing the catalyst of the reaction system. did.
이들의 반응후 반응용매를 감압하에서 증류제거하고 생성물을 그대로 사용하거나 용매등으로 분배해서 사용해도 좋고 컬럼크로마트법이나 재결정법 등으로 정제해도 좋다.After these reactions, the reaction solvent may be distilled off under reduced pressure and the product may be used as it is, or may be distributed in a solvent or the like, or may be purified by column chromatography or recrystallization.
이와 같이해서 얻어진 반응생성물에는 일반식(3)에서 나타낸 벤조페논유도체외에 일반식(3)에서 n이 4개이상의 화합물, 염, 미반응의 당과 당알콜이 공존하고 있다.In the reaction product thus obtained, in addition to the benzophenone derivative represented by the general formula (3), n or more compounds, salts, unreacted sugars and sugar alcohols in the general formula (3) coexist.
따라서 예를 들면 당과 당알콜, 염을 제거한 경우에는 메틸알콜, 에틸알콜, 부틸알콜, 이소프로필알콜등의 용매로 추출하거나 염을 다량으로 포함하는 물과 메틸에틸케톤, n-부탄올등으로 분배하고 유기용매층을 분취함으로서 정제할 수 있다.Thus, for example, when sugars, sugar alcohols, and salts are removed, they are extracted with a solvent such as methyl alcohol, ethyl alcohol, butyl alcohol, isopropyl alcohol, or partitioned into water containing a large amount of salt, methyl ethyl ketone, n-butanol, and the like. It can refine | purify by separating an organic solvent layer.
또한 당 및 당알콜과 염을 제거하고 화합물을 분리할 경우, 반응생성물을 물 또는 물과 알콜의 혼액에 현탁시켜 하이퍼플러스폴리마(예를 들면 미쯔미시 화성공업 주식회사제의 하이플러스수지), 옥타데실실리카등의 역상분배컬럼으로 처음에는 물로 통과시키고 다음으로 메탄올, 에탄올등의 알콜과 아세트니트릴 등의 극성유기용매와 물의 혼액으로 통과시켜 이 액을 분취함으로서 정제할 수 있다.In addition, when the sugar, sugar alcohol and salt are removed and the compound is separated, the reaction product is suspended in water or a mixture of water and alcohol, and hyperplus polymer (for example, Hiplus resin manufactured by Mitsumi Chemical Co., Ltd.), octadecyl It can be purified by separating the liquid by first passing it through water with a reverse phase-distributing column such as silica and then passing it through a mixture of alcohol, such as methanol and ethanol, polar organic solvent such as acetonitrile and water.
또한 염등을 제거한 후 실리카겔칼럼 크로마토그래피법등의 순상계를 정제할 수 있다.Furthermore, after removing a salt etc., pure phase systems, such as a silica gel column chromatography method, can be refine | purified.
그런데 수용성의 자외선흡수제로서는 계의 pH에 미치는 영향을 저감시킴으로서 비이온성 친수기를 도입한 수용성의 자외선흡수제가 바람직하다.As the water-soluble ultraviolet absorber, a water-soluble ultraviolet absorber incorporating a nonionic hydrophilic group is preferable by reducing the effect on the pH of the system.
비이온성의 친수기로서는 주로 폴리에틸렌옥사이드, 폴리글리세린, 당등을 얻을 수 있다.As a nonionic hydrophilic group, mainly polyethylene oxide, polyglycerol, a sugar, etc. can be obtained.
이들 중 폴리에틸렌옥사이드는 경시로 분해되고 포르마린을 발생하는 등 그 자신이 디옥산을 포함하고 있는점 등에서 최근 안정성면에서 바람직하지 않다고 생각되어 왔다.Among them, polyethylene oxide has been considered to be unfavorable in terms of stability recently, in that it contains dioxane such as decomposing over time and generating formarin.
이 관점에서는 안전성이 높은 폴리글리세린과 당이 바람직하다. 한편, 기제는 단 일성분인 것이 요구되고 있지만, 폴리에틸렌옥사이드와 폴리글리세린은 그 합성반응의 성질상, 부가수의 분포를 가진 혼합물로 되기 쉽고, 또한 이 때문에 정제도 용이하지 않다.From this point of view, polyglycerol and sugar with high safety are preferred. On the other hand, although the base is required to be a single component, polyethylene oxide and polyglycerol tend to be a mixture having a distribution of added water due to the nature of the synthesis reaction, and for this reason, purification is not easy.
이에 대해 당과 같은 친수기는 생성물이 혼합물로 되기 어렵고, 정제도 용이하다는 점에서 바람직하다 할 수 있다.On the other hand, a hydrophilic group such as sugar may be preferable in that the product is less likely to be a mixture and the purification is easy.
그러나 당에 직접 에테르화나 에스테르화 등의 반응을 실시하면 역시 부가몰수의 차이에 의한 혼합물이 된다는 문제점이 있었다.However, there is a problem in that when a reaction such as etherification or esterification is performed directly on sugars, it becomes a mixture due to the difference in the number of added moles.
그래서 본 발명자들은 이러한 문제를 해결하기 위해 다음과 같은 벤조페논유도체를 개발한 것이다.Thus, the present inventors have developed the following benzophenone derivatives to solve this problem.
즉 본 발명의 제7항 기재의 벤조페논유도체는 하기 일반식(7)로 나타낸다.That is, the benzophenone derivative of Claim 7 of this invention is represented by following General formula (7).
(상기 일반식(7)에서, R1, R2는 수소 또는 수산기이고, 한 개 이상이 수산기이며, R3∼R10은 수소 또는 수산기, 또는 C1-4의 알콕시기 또는 -O-R-O-A로 나타내고, 한 개가 -O-R-O-A로 나타내며, A는 당에서 한 개의 수산기를 제거한 잔기, R은 C1-4의 지방사슬이다)(In general formula (7), R <1> , R <2> is hydrogen or a hydroxyl group, one or more is a hydroxyl group, R <3> -R <10> is represented by hydrogen or a hydroxyl group, or the C 1-4 alkoxy group or -OROA. , One is represented by -OROA, A is a residue from which one hydroxyl group is removed from sugar, R is C 1-4 fatty chain)
제8항 기재의 자외선흡수제는 상기 일반식(7)의 벤조페논유도체를 1종 또는 2종 이상을 포함한 것을 특징으로 한다.The ultraviolet absorbent of Claim 8 contains 1 type, or 2 or more types of the benzophenone derivatives of the said General formula (7).
제9항 기재의 피부외용제는 상기 일반식(7)의 벤조페논유도체를 1종 또는 2종 이상을 포함한 것을 특징으로 한다.The skin external preparation of Claim 9 contains 1 type, or 2 or more types of the benzophenone derivatives of the said General formula (7).
상기 일반식(7)에 있어서 A는 당의 잔기이고, 당의 구체예로서는 글루코스, 갈락토스, 크실로스, 프룩토스, 알토로스, 타로스, 만노스, 아라비노스, 이도스, 릭키소스, 리보오스, 아로스 등의 단당류 및 그 혼합물, 또는 말토스, 이소말토스, 락토스, 크실로비오스, 켄티오비오스, 코디오비오스, 셀로비오스, 소호로스, 니게로스, 수크로스, 메리비오스, 라미나리비오스, 루티노스 등의 이당류 및 그 혼합물, 또는 말토트리오스 등의 삼당류 및 그 혼합물 또한 그 이상의 다당 및 그 혼합물 또한 이들의 단당, 이당 그 이상의 다당 혼합물을 사용하는 것도 가능하다.In Formula (7), A is a residue of a sugar, and specific examples of the sugar include monosaccharides such as glucose, galactose, xylose, fructose, altorose, talos, mannose, arabinose, idos, rickissos, ribose, and aros. And mixtures thereof, or disaccharides such as maltose, isomaltose, lactose, xylobiose, kenthiobis, cordiobis, cellobiose, sohorose, nigerose, sucrose, meribios, laminaribiose, and lutinos. And mixtures thereof, or trisaccharides such as maltotriose, and mixtures thereof, and further polysaccharides and mixtures thereof, and also mixtures of monosaccharides, disaccharides and more thereof.
R3∼R10에 있어서, O-R-O-A를 사용할 경우 R이 되는 지방사슬은 직쇄알킬기, 분기알킬기, 불포화알킬기, 시클로알킬기 어느 것이라도 좋고, 지방사슬의 구체예로서는 메틸기, 에틸기, 아세티레닐기, 프로필기, 이소프로필기, 프로페닐기, 부틸기, 이소부틸기, t-부틸기, 부테닐기등을 들 수 있다.In R 3 to R 10 , in the case of using OROA, the aliphatic chain to be R may be a straight chain alkyl group, a branched alkyl group, an unsaturated alkyl group or a cycloalkyl group. Specific examples of the aliphatic chain include a methyl group, an ethyl group, an acetylenyl group, a propyl group, Isopropyl group, propenyl group, butyl group, isobutyl group, t-butyl group, butenyl group and the like.
모두다 자외선 흡수파장에 현저한 차이는 없지만 공업성등에서 특히 메틸기, 에틸기가 바람직하다.Although there is no remarkable difference in the ultraviolet absorption wavelength in all, methyl group and ethyl group are preferable especially in industrial use.
또한 R3∼R10에 있어서 알콕시기를 사용할 경우 해당 알콕시기의 지방사슬 또는 직쇄알콕시기, 분기알콕시기, 불포화알콕시기, 시클로알콕시기중 어느 것이라도 좋고 구체적으로는 메톡시기, 에톡시기, 아세틸레닐옥시기, 프로필옥시기, 이소프로필옥시기, 프로페닐옥시기, 부틸옥시기, 이소부틸옥시기, t-부틸옥시기, 부테닐옥시기등을 들 수 있다.In the case of using an alkoxy group in R 3 to R 10 , any of an aliphatic chain or a linear alkoxy group, a branched alkoxy group, an unsaturated alkoxy group or a cycloalkoxy group of the alkoxy group may be used, and specifically, a methoxy group, an ethoxy group and an acetylenyl jade. A time period, a propyloxy group, an isopropyloxy group, a propenyloxy group, a butyloxy group, an isobutyloxy group, t-butyloxy group, butenyloxy group, etc. are mentioned.
모두 자외선흡수파장에 현저한 사슬은 없지만 수용성등과 공업성등에서 특히 메톡시기, 에톡시기가 바람직하다.Although there is no noticeable chain in ultraviolet absorption wavelength in all, a methoxy group and an ethoxy group are especially preferable in water solubility etc. and industrial uses.
상기의 벤조페닐페논유도체는 고체로 안전성, 안정성이 상당히 우수하기 때문에 도료나 잉크, 플라스틱코팅제, 화학섬유등의 화학제품등으로 배합할 수 있는 한편 의약품, 화장재료 및 세정료의 성분으로서 배합될 수 있다. 상기 일반식(7)에 관련된 벤조페놀유도체는 예를 들면 특개소 63-84637에 기재된 당류변성용산촉매를 사용해서 합성할 수 있는외에 일반적으로 글리코실화에 사용되고 있는 반응(케닉힉크놀반응, 헥페라이히법 혹은 그 이외의 에테르교환법)을 사용해도 좋다.Since the benzophenylphenone derivative is solid and has excellent safety and stability, it can be blended with chemicals such as paints, inks, plastic coating agents, and chemical fibers, and can be blended as a component of pharmaceuticals, cosmetics, and cleaning agents. have. The benzophenol derivatives related to the general formula (7) can be synthesized using, for example, a saccharide-modified lysis catalyst described in Japanese Patent Application Laid-Open No. 63-84637, and are generally used for glycosylation (Kenic Schenkol Reaction, Hepereihi). Method or other ether exchange method) may be used.
예를 들면 다음과 같이 합성할 수 있다.For example, it can synthesize as follows.
당의 아세틸화물을 디부필셀로솔브, 톨루엔등의 무극성용매로 하거나 또는 무용매로 일반식(8)The acetylide of sugar is made into nonpolar solvent such as dibufilcellosolve, toluene, or without solvent (8)
(단, 식중 R1, R2는 전기화학실(2)과 동일, R3∼R10은 수소, 수산기, 알콕시기 또는 O-R-OH로 나타내고 한 개 이상을 O-R-OH로 나타낼 수 있다. 알콕시기는 바람직하게는 탄소수 1∼4, R은 지방사슬, 바람직하게는 탄소수 1∼4를 나타낸다)에서 나타낸 화합물을 첨가하고 산촉매의 존재하에서 90∼130℃로 교반, 반응은 감압하에서 실시하고 일반식(8)에서 나타낸 화합물은 단독 또는 2종이상으로 병용해도 좋다.(Wherein R 1 and R 2 are the same as in the electrochemical chamber (2), and R 3 to R 10 may be represented by hydrogen, a hydroxyl group, an alkoxy group or OR-OH and at least one may be represented by OR-OH.) Preferably, the compound having 1 to 4 carbon atoms and R represents an aliphatic chain, preferably 1 to 4 carbon atoms is added, and the mixture is stirred at 90 to 130 ° C. in the presence of an acid catalyst, and the reaction is carried out under reduced pressure. The compound shown by () may be used alone or in combination of two or more.
이 때 사용된 촉매로서는 p-톨루엔설폰산, 헤테로폴리인산, 초산아연, 염화아연 혹은 이온교환수지등을 들 수 있다.Examples of the catalyst used at this time include p-toluenesulfonic acid, heteropolyphosphoric acid, zinc acetate, zinc chloride or ion exchange resins.
반응후 반응용매를 감압하 증류제거하고, 생성물을 톨루엔 유출하고 수세한다.After the reaction, the reaction solvent is distilled off under reduced pressure, and the product is extracted with toluene and washed with water.
얻어진 유출액을 감압농축 후 그대로 탈아세틸화하든가. 실리카겔칼럼크로마토법으로 정제한 후 탈아세틸화해도 좋다.The obtained effluent is deacetylated as it is after concentration under reduced pressure. After purification by silica gel column chromatography, deacetylation may be performed.
이렇게 해서 얻어진 반응생성물에는 일반식(7)에서 나타낸 벤조페논유도체외에 중화시의 염, 당등이 공존하고 있다.In the reaction product thus obtained, salts and sugars during neutralization coexist in addition to the benzophenone derivatives represented by the general formula (7).
따라서 예를 들면 당과 염을 제거할 경우 메틸알콜, 에틸알콜, 부틸알콜, 이소프로필알콜등의 당을 용해하지 않은 용매로 추출하거나 염을 다량으로 포함하는 물과 메틸에틸케논, n-부탄올로 분배해서 유기용매층을 분취함으로서 정제할 수 있다.Thus, for example, to remove sugars and salts, extract with a solvent that does not dissolve sugars such as methyl alcohol, ethyl alcohol, butyl alcohol and isopropyl alcohol, or water containing a large amount of salt, methyl ethyl kenone and n-butanol. It can divide and refine | purify by separating an organic solvent layer.
또한 당과 염을 제거해서 벤조페논유도체를 분리할 경우, 반응생성물을 물 또는 물과 알콜의 혼액으로 현탁시키고 하이퍼플러스포리머(예를 들면 미쯔비시화성공업 주식회사제의 하이플러스수지)옥타데실실리카등의 역상분배칼럼으로 처음에는 물로 통과시키고 다음으로 메탄올, 에탄올등의 알콜과 아세토니트릴등의 극성유기용매와 물의 혼액으로 통과시켜 이 액을 분취함으로서 생성할 수 있다.In addition, when benzophenone derivatives are separated by removing sugars and salts, the reaction product is suspended in water or a mixture of water and alcohol, and a hyperplus polymer (for example, a high plus resin manufactured by Mitsubishi Chemical Corporation) octadecyl silica, etc. It can be produced by separating the liquid by first passing it through water as a reverse phase distribution column and then passing it through a mixture of alcohols such as methanol and ethanol, polar organic solvents such as acetonitrile and water.
전술한 벤조페논유도체는 추출용매를 증류제거하거나 칼럼에 의해 정제한 후 사용해도 좋고 그대로 사용해도 좋다.The above-described benzophenone derivative may be used after distilling off the extraction solvent or purifying by column.
이렇게 해서 얻어진 벤조페논유도체는 화학안정성, 산화안정성에 뛰어나고 수용성이며 자외선영역에 흡수를하는 한편 보습성이 뛰어나다는 기능을 갖는다.The benzophenone derivative thus obtained is excellent in chemical stability, oxidation stability, water solubility, absorbed in the ultraviolet region, and excellent in moisture retention.
본 발명의 벤조페논유도체는 안전성이 뛰어나기 때문에 화장재료, 의약재료등에 배합할 수 있다.Since the benzophenone derivative of this invention is excellent in safety, it can be mix | blended with cosmetics, a pharmaceutical material, etc.
또한 본 발명에 첨가해서 통상 사용되는 외의 화장재료나 의료재료성분을 적당하게 배합할 수 있다.In addition to the present invention, cosmetic materials and medical material components other than those commonly used can be appropriately blended.
예를 들면 유동파라핀, 스쿠알렌, 바세린, 세틸알콜, 이소스테라일알콜, 2-에틸헥산산세틸, 2-옥틸도데실알콜, 트리이소스테아린산글리세린, 마카데미안너트유, 라놀린등의 각종 탄화수소, 유지류, 로우류등의 유성성분, 실리콘류, 계면활성제, 증점제, 중화제, 방부제, 살균제, 산화방지제, 분체성분, 색소, 향료 그밖의 자외선흡수제, 약효제, 금속봉쇄제, pH조제제등을 들 수 있다.For example, various hydrocarbons, fats and oils, such as liquid paraffin, squalene, petrolatum, cetyl alcohol, isosateyl alcohol, 2-ethylhexanoate cetyl, 2-octyldodecyl alcohol, triisostearic acid glycerin, macadamian nut oil and lanolin, Oily ingredients such as Rowe, silicones, surfactants, thickeners, neutralizers, preservatives, fungicides, antioxidants, powder components, pigments, flavorings and other ultraviolet absorbers, drugs, metal blockers, pH preparations, and the like. .
[실시예]EXAMPLE
이하 본 발명의 실시예를 나타내지만 이는 본 발명의 기술적 범위를 한정하는 것은 아니다.Examples of the present invention are shown below, but this does not limit the technical scope of the present invention.
배합량은 중량 %이다.The compounding amount is weight%.
[실시예 1]Example 1
1-(4-벤조일페닐)글리세롤멀티톨루에테르1- (4-benzoylphenyl) glycerol multitoluether
4-히드록시벤조페논 1g, 에피크롤히드린 4.668g(0.025mol)을 용해한 후 수산화나트륨 20.54㎎을 첨가하고 반응계를 100°까지 승온한 후 95。로해서 수산화나트륨 201.4㎎을 첨가하는 한편 가열교반을 3시간 실시했다.After dissolving 1 g of 4-hydroxybenzophenone and 4.668 g (0.025 mol) of epichlorohydrin, 20.54 mg of sodium hydroxide was added, the reaction system was heated to 100 °, and 201.4 mg of sodium hydroxide was added thereto at 95 ° C., followed by heating and stirring. Was carried out for 3 hours.
계를 실온까지 냉각한 후 염을 여과해서 제거했다.After cooling the system to room temperature, the salt was filtered off.
얻어진 여과액을 감압농축해서 실리카겔칼럼크로마토법으로 정제하면 고체상의 4-글리시딜옥시벤조페논이 1.0g(수율83%)얻어졌다.The obtained filtrate was concentrated under reduced pressure and purified by silica gel column chromatography to obtain 1.0 g (yield 83%) of 4-glycidyloxybenzophenone as a solid.
다음에 멀티톨 2.921g, 수산화칼륨 476.0㎎을 디메틸설폭시드 20㎖로 용해하고 질소기류하에서 30분간 가열교반한 후 얻어진 4-글리시딜옥시벤조페논 719㎎을 디메틸설폭사이드 1㎖로 용해한 용액을 떨어뜨렸다.Next, a solution in which 921 mg of 4-glycidyloxybenzophenone was dissolved in 1 ml of dimethyl sulfoxide was dissolved by dissolving 2.921 g of multitol and 476.0 mg of potassium hydroxide in 20 ml of dimethyl sulfoxide, followed by heating and stirring for 30 minutes under a nitrogen stream. Dropped.
또한 질소기류하에서 가열교반을 1시간 실시한 후 실온까지 냉각하고 염산으로 중화했다.The mixture was further stirred for 1 hour under a nitrogen stream, cooled to room temperature and neutralized with hydrochloric acid.
반응계를 하이퍼폴라스폴리머(미쯔비시화성공업 주식회사)제의 하이폴라스수지)의 칼럼크로마토그래피법으로 전개용매로서 처음에는 정제수, 다음에는 메틸알콜 : 정제수 = 1 : 1을 사용해서 구획하고 에틸알콜 : 정제수 = 1 : 1 용출부를 농축해서 1-(4-벤조일페닐) 글리세롤멀티톨루에테르를 500㎎(흡수율 30%)을 얻었다.The reaction system was partitioned using a column chromatography method of a hyperpolar polymer (Hipolar resin made by Mitsubishi Chemical Co., Ltd.) as a developing solvent, first using purified water, followed by methyl alcohol: purified water = 1: 1, and then ethyl alcohol: Purified water = 1: 1 The eluate was concentrated to obtain 500 mg (absorption rate 30%) of 1- (4-benzoylphenyl) glycerol multitoluether.
(1) 적외흡수 스펙트럼측정법.(1) Infrared absorption spectrometry.
일본분광공업 주식회사제, IRA-1적외선흡수스펙트럼 측정장치를 사용하고 KBr정제법으로 측정한 결과 3387㎝-1에 수산기의 신축진동, 2928㎝-1에 글리세로일기의 신축진동, 1649㎝-1에 카르보닐기의 신축운동에 의한 흡수가 관측되었다.As measured by KBR method using IRA-1 infrared absorption spectrum measuring device manufactured by Nippon Kagaku Kogyo Co., Ltd., the expansion vibration of hydroxyl group is 3387 cm -1 , the expansion vibration of glycerol group is 2928cm -1 , and 1649 cm -1. Absorption by stretching of the carbonyl group was observed.
결과를 제1도에 나타낸다.The results are shown in FIG.
(2)13C-NMR측정법(2) 13 C-NMR Measurement
일본전자 주식회사 제품 JOEL GX-400 에 의해, CD3OD를 용매로서 35℃로 측정한 결과 δ197ppm, 164ppm, 139ppm, 134ppm, 133ppm, 131ppm, 129ppm, 115ppm로 벤조페논부분의 탄소에 유래하는 시그날이 103ppm∼62ppm으로 멀티톨기와 그리세릴기에 유래하는 시그날이 각각 관측되었다.JOEL GX-400 manufactured by Nippon Electronics Co., Ltd. measured CD 3 OD at 35 ° C. as a solvent, and the signal derived from carbon of the benzophenone portion was δ197ppm, 164ppm, 139ppm, 134ppm, 133ppm, 131ppm, 129ppm, 115ppm. Signals derived from the multitol group and the gglyceryl group were observed at ˜62 ppm, respectively.
결과를 제2도에 나타낸다.The results are shown in FIG.
(3)1H-NMR측정법(3) 1 H-NMR measurement
일본전자 주식회사제의 JOEL GX-400 에 의해, CD3OD를 용매로서 실온으로 측정한 결과 δ7.8ppm∼7.1ppm으로 벤조페논부분의 수소에 유래하는 시그날이 δ5.2ppm∼3.3ppm으로 멀티톨기와 글리세릴기의 수소에 유래하는 시그날이 각각 관측되었다.JOEL GX-400 manufactured by Nippon Electronics Co., Ltd. measured CD 3 OD at room temperature as a solvent. As a result, a signal derived from hydrogen of the benzophenone moiety was δ5.2 ppm to 3.3 ppm at δ7.8 ppm to 7.1 ppm. The signals derived from hydrogen of the glyceryl group were observed, respectively.
결과를 제3도에 나타낸다.The results are shown in FIG.
(4) 자외선흡수스펙트럼측정법(4) UV absorption spectrum measurement method
일본분광공업 주식회사 UVIDEC 61OC 자외선흡수스펙트럼측정장치를 상용하고 용매메탄올로 측정한 결과 282.7nm으로 극대흡수를 나타냈다.Nippon Spectroscopy Industry Co., Ltd. UVIDEC 61OC UV absorption spectrum measurement device was commercially available and measured by solvent methanol showed maximum absorption at 282.7nm.
결과를 제4도에 나타낸다.The results are shown in FIG.
(5) 페놀지시약(5) Phenolic Reagents
생성물 JLC 상에 스팟팅해서 분무기로 페놀지시약을 분부한 후 계속해서 10% 탄산수소나트륨수용액을 분무해도 페놀이 있었던 경우의 색을 나타내지 않았다.Spotting on the product JLC and dispensing the phenol indicators with a nebulizer followed by spraying with a 10% aqueous sodium hydrogen carbonate solution did not give a color when phenol was present.
[실시예 2]Example 2
1-(4-벤조일-3-히드록시페닐) 글리세롤멀티톨루에테르1- (4-benzoyl-3-hydroxyphenyl) glycerolmultitoluether
2, 4-히드록시벤조페논 3.0g, 에피크롤히드린 15.55g(0.075mol)을 용해한 후 수산화나트륨 112.0㎎을 첨가하고 반응계를 100°까지 승온한 후 95°로 해서 수산화나트륨 672.2㎎을 첨가하는 한편 가열교반을 3시간 실시했다.2,4-hydroxybenzophenone 3.0g and epichlorohydrin 15.55g (0.075mol) were dissolved, and sodium hydroxide 112.0 mg was added.The reaction system was heated to 100 ° and sodium hydroxide 672.2 mg was added. On the other hand, heat stirring was performed for 3 hours.
계를 실온까지 냉각한 후 염을 여과해서 제거했다.After cooling the system to room temperature, the salt was filtered off.
얻어진 여과액을 감압농축해서 실리카겔칼럼크로마토법으로 정제하면 고체상의 4-글리시딜옥시-2-히드록시벤조페논이 2.8216g(수율 75%) 얻어졌다.The obtained filtrate was concentrated under reduced pressure and purified by silica gel column chromatography to obtain 2.8216 g (yield 75%) of solid 4-glycidyloxy-2-hydroxybenzophenone.
다음에 멀티톨 1.550g, 수산화칼륨 84.2㎎을 디메틸설폭시드 10㎖로 용해하고 질소기류하에서 30분간 가열교반한 후 얻어진 4-글리시딜옥시-2-히드록시벤조페논 406.0㎎을 디메틸설폭사이드 6㎖로 용해한 용액을 떨어뜨렸다.Next, 1.550 g of multitol and 84.2 mg of potassium hydroxide were dissolved in 10 ml of dimethyl sulfoxide and heated and stirred for 30 minutes under a stream of nitrogen to obtain 406.0 mg of 4-glycidyloxy-2-hydroxybenzophenone obtained by dimethyl sulfoxide 6 The solution dissolved in mL was dropped.
또한 질소기류하에서 가열교반을 1시간 실시한 후 실온까지 냉각하고 염산으로 중화했다.The mixture was further stirred for 1 hour under a nitrogen stream, cooled to room temperature and neutralized with hydrochloric acid.
반응계를 하이퍼폴라스폴리머(미쯔비시화성공업 주식회사)제의 하이폴라스수지)의 칼럼크로마토그래피법으로 전개용매로서 처음에는 정제수, 다음에는 메틸알콜 : 정제수 = 1 : 1을 사용해서 구획하고 에틸알콜 : 정제수 = 1 : 1 용출부를 농축해서 1-(4-벤조일-3히드록시페닐) 글리세롤멀티톨루에테르를 478㎎(흡수율52%)을 얻었다.The reaction system was partitioned using a column chromatography method of a hyperpolar polymer (Hipolar resin made by Mitsubishi Chemical Co., Ltd.) as a developing solvent, first using purified water, followed by methyl alcohol: purified water = 1: 1, and then ethyl alcohol: Purified water = 1: 1 The eluate was concentrated to give 478 mg (absorption rate: 52%) of 1- (4-benzoyl-3hydroxyphenyl) glycerol multitoluether.
(1) 적외흡수스펙트럼측정법.(1) Infrared absorption spectrum measurement method.
일본분광공업 주식회사제, IRA-1 적외흡수스펙트럼 측정장치를 사용하고 KBr 정제법으로 측정한 결과 3380㎝-1에 수산기의 신축진동, 2928㎝-1에 탄화수소기의 신축진동, 1626㎝-1에 카르보닐기의 신축운동에 의한 흡수가 관측되었다.Japanese minutes Mining Co., Ltd., IRA-1 using infrared absorption spectrum measuring apparatus, and the stretching vibration of the hydrocarbon group in the stretching vibration, 2928㎝ -1 of the hydroxyl group in the resulting 3380㎝ -1 as measured by a KBr tablet method, 1626㎝ -1 Absorption by stretching of the carbonyl group was observed.
결과를 제5도에 나타낸다.The results are shown in FIG.
(2)13C-NMR측정법(2) 13 C-NMR Measurement
일본전자 주식회사 제품 JOEL GX-400에 의해, CD3OD를 용매로서 35℃로 측정한 결과 δ201ppm, 166ppm, 139ppm, 136ppm, 133ppm, 132ppm, 130ppm, 129ppm, 114ppm에 벤조페논부분의 탄소에 유래하는 시그날이 109ppm∼62ppm으로 멀티톨기와 그리세릴기에 유래하는 시그날이 각각 관측되었다.JOEL GX-400 manufactured by Nippon Electronics Co., Ltd. measured the CD 3 OD at 35 ° C. as a solvent. At 109 ppm to 62 ppm, signals derived from the multitol group and the glyceryl group were observed, respectively.
결과를 제6도에 나타낸다.The results are shown in FIG.
(3)1H-NMR측정법(3) 1 H-NMR measurement
일본전자 주식회사제의 JOEL GX-400에 의해, CD3OD를 용매로서 실온으로 측정한 결과 δ12.5ppm, 7.8∼7.1ppm으로 벤조페논부분의 수소에 유래하는 시그날이 δ5.2ppm∼3.3ppm으로 멀티톨기와 글리세릴기의 수소에 유래하는 시그날이 각각 관측되었다.JOEL GX-400 manufactured by Nippon Electronics Co., Ltd. measured CD 3 OD at room temperature as a solvent. The signal derived from hydrogen of the benzophenone moiety was δ5.2 ppm to 3.3 ppm at δ12.5 ppm and 7.8 to 7.1 ppm. Signals derived from hydrogen of the tall group and the glyceryl group were observed, respectively.
결과를 제7도에 나타낸다.The results are shown in FIG.
(4) 자외선흡수스펙트럼측정법(4) UV absorption spectrum measurement method
일본분광공업 주식회사 UVIDEC 61OC 자외선흡수스펙트럼측정장치를 상용하고 용매메탄올로 측정한 결과 279.8㎚으로 극대흡수를 나타낸다.Japan Spectrophotometer Co., Ltd. UVIDEC 61OC Ultraviolet absorption spectrum measuring apparatus was used and measured with solvent methanol, and shows the maximum absorption at 279.8 nm.
결과를 제8도에 나타낸다.The results are shown in FIG.
(5) 페놀지시약(5) Phenolic Reagents
주성물을 JLC상에 스팟팅해서 분무기로 페놀지시약을 분부한 후 계속해서 10%탄산수소나트륨수용액을 분무해도 페놀이 있었던 경우의 색을 나타내지 않았다.After spotting the main substance on JLC and dispensing the phenolic indicator with an atomizer, spraying 10% aqueous sodium hydrogen carbonate solution did not show the color when phenol was present.
[실시예 3]Example 3
4,4′-멀티트이록시글리세록시-2,2′히드록시벤조페논4,4'- multi hydroxy glyceroxy -2,2 'hydroxy benzophenone
2,2′,4,4′-테트라히드록시벤조페논 3.0g, 에피크롤히드린 31.1g(0.075mol)을 용해한 후 수산화나트륨 2240.0㎎을 가해 반응계를 100℃까지 승온한 후 95℃로 해서 수산화나트륨을 가하는 한편 가열교반을 3시간 실시했다.After dissolving 3.0 g of 2,2 ', 4,4'-tetrahydroxybenzophenone and 31.1 g (0.075 mol) of epichlorohydrin, 2240.0 mg of sodium hydroxide was added thereto, and the reaction system was heated up to 100 ° C. and then set at 95 ° C. Sodium was added and heat stirring was performed for 3 hours.
계를 실온까지 냉각한 후 염을 여과해 제거했다.After cooling the system to room temperature, the salt was filtered off.
얻어진 여과액을 감압농축하고 실리카겔칼럼크로마토법으로 정제하면 고체상의 4', 4-디글리시딜옥시-2,2′-히드록시벤조페논이 3.21g 얻어졌다.The obtained filtrate was concentrated under reduced pressure and purified by silica gel column chromatography to obtain 3.21 g of 4 Pa, 4-diglycidyloxy-2,2'-hydroxybenzophenone as a solid.
다음에 멀티톨 1.550g, 수산화칼륨 84.2㎎을 디멜틸설폭사이드 10㎖로 용해하고 질소기류하에서 30분간 가열교반한 후 얻어진 4'4, -디글리시딜옥시-2,2'-디히드록시벤조페논 606.0㎎을 디메틸설폭시드 7㎖에 용해한 용액을 떨어뜨렸다.Next, 4'4, -diglycidyloxy-2,2'-dihydroxy obtained by dissolving 1.550 g of multitol and 84.2 mg of potassium hydroxide in 10 ml of dimeltyl sulfoxide and heating and stirring for 30 minutes under a nitrogen stream. The solution which melt | dissolved 606.0 mg of benzophenone in 7 ml of dimethyl sulfoxide was dropped.
또한 질소기류하에서 가열교반을 1시간 실시한 후 실온까지 냉각해서 염산으로 중화했다.The mixture was further stirred for 1 hour under a nitrogen stream, cooled to room temperature, and neutralized with hydrochloric acid.
반응을 하이퍼폴라스폴리머(미쯔비시화성공업 주식회사제의 하이퍼폴라스수지(의 칼럼크로마토그래프법으로 전개용매로서 처음에 정제수, 다음으로 에테르알콜 : 정제수 = 1 : 1을 사용해서 구분하고 에테르알콜 : 정제수 = 1 : 1 용출부를 농축하며 4,4′-멀티트이록시글리세록시-2,2′-히드록시벤조페논을 780㎎을 얻었다.The reaction was first divided into purified solvent and then using ether alcohol: purified water = 1: 1 as a developing solvent by the column chromatograph method of the hyperpolar polymer (Hyperpolar resin made by Mitsubishi Chemical Industries, Ltd.) and ether alcohol: purified water. = 1: 1 The elution part was concentrated and 780 mg of 4,4'- multi hydroxy glyceroxy-2,2'- hydroxy benzophenone was obtained.
[시험예 1][Test Example 1]
미용액의 제조Preparation of Serum
표1과 같은 처방으로 벤조페논유도체를 배합한 미용액과 대조예로서 2-히드록시-4-메톡시-5-설폭소늄벤조페논을 배합한 미용액의 제조를 실시했다.In the formulation shown in Table 1, a cosmetic solution containing a benzophenone derivative was prepared, and a cosmetic solution containing 2-hydroxy-4-methoxy-5-sulfonium benzophenone as a control example was prepared.
[표 1]TABLE 1
알콜상 A를 수상B에 첨가해서 향료를 가용화해서 미용액을 얻었다.Alcohol phase A was added to the aqueous phase B to solubilize the perfume to obtain a cosmetic liquid.
배합예1은 무색투명하고 점성이 있는 양호한 미용액을 얻을 수 있는 것에 대해 대조예1은 황색기미가 강하고 점성이 없는 것이였다.The compounding example 1 was colorless, transparent and viscous, and the favorable cosmetic liquid was obtained, whereas the comparative example 1 was a strong yellowish tinge and no viscosity.
[시험예 2][Test Example 2]
자외선(햇빛)차단테스트UV light blocking test
시험예1에서 제조한 2개의 미용액을 사용해서 해변에서 직접 사용해 테스트 했다.Two essences prepared in Test Example 1 were used and tested directly on the beach.
방법으로서는 샘플을 남녀 각 20명의 배에 좌우반씩 도포하고 햇빛에 탄정도를 판정했다.As a method, the sample was apply | coated to the tummy of 20 men and women, and the degree of sunburn was determined.
햇빛의 탄정도의 평가기준Evaluation standard of sunlight degree of sunlight
진한적색얼굴을 인정할 수 있었다····×A dark red face was recognized ...
조금 진한적색얼굴을 인정할 수 있었다····△A little dark red face was recognized ...
적색얼굴을 인정할 수 없었다····○Red face could not be recognized
결과를 표2에 나타낸다.The results are shown in Table 2.
[표 2]TABLE 2
이들의 결과로부터 벤조페논유도체를 배합한 피부외용제는 종래의 수용성 자외선흡수제를 배합한 피부외용제보다도 자외선 방어효과가 높고 피부트러블도 없어 안전성이 높은 것이었다.From these results, the skin external preparation containing the benzophenone derivative was higher in the UV protective effect and safer than the skin external preparation incorporating the conventional water-soluble ultraviolet absorbent.
[시험예 3][Test Example 3]
보습성Moisturizing
실온 25℃ 50% 상대습도의 환경하에서 남녀 15명의 피부전도변화를 측정했다.The skin conduction change of 15 men and women was measured in an environment of 25 ° C. and 50% relative humidity.
시험예1에서 제조한 미용액을 어깨부분에 바르고 그 처리후 24시간 경과후의 어깨부의 피부전도를 측정하고 그 증가율에서 판정을 했다.The cosmetic liquid prepared in Test Example 1 was applied to the shoulder portion, and skin conduction of the shoulder portion after 24 hours after the treatment was measured and judged at the increase rate.
전도증가율 = 전도치의 증가량/처리전 전도치Conductivity increase rate = increase in conduction value / conduction value before treatment
전도증가율 15%····×15% increase in conduction rate
전도증가율 15%이상 30%미만····△Conduction growth rate 15% or more but less than 30%
전도증가율 30%이상····○More than 30% increase in conduction rate
결과는 표3과 같이 되었다.The results are shown in Table 3.
[표 3]TABLE 3
이상의 결과로부터, 본 발명에 관련된 벤조페논유도체를 배합한 피부외용제는 종래는 수용성자외선흡수제를 배합한 피부외용제보다 보습성이 높은 우수한 것이라는 것을 알았다.From the above results, it has been found that the external skin preparations incorporating the benzophenone derivative according to the present invention have superior moisturizing properties than the external skin preparations incorporating a water-soluble ultraviolet absorbent.
[실시예 4]Example 4
2-히드록시4-(2-말토실옥시에톡시)벤조페논2-hydroxy4- (2-maltosyloxyethoxy) benzophenone
2,4-디히드록시벤조페논 1g을 에틸브로머히드린 7g, 수산화나트륨 37㎎, 정제수 0.25g을 첨가해 용해했다.1 g of 2,4-dihydroxybenzophenones were dissolved by adding 7 g of ethyl bromerhydrin, 37 mg of sodium hydroxide, and 0.25 g of purified water.
100℃까지 가열교반한 후 90℃로 낮추고 다시 수산화나트륨 224㎎을 가했다.After stirring and heating to 100 ° C., the mixture was lowered to 90 ° C. and 224 mg of sodium hydroxide was added thereto.
2시간 가열교반후 냉각하고 클로로포름으로 추출, 수세후 건조, 농축했다.After 2 hours of heating stirring, the mixture was cooled, extracted with chloroform, washed with water, dried and concentrated.
실리카겔칼럼크로마토그래피법(톨루엔 : 메틸에틸케톤)을 사용해서 정제하고 2-히드록시4-(2-히드록시에톡시)벤조페논을 1.1g을 얻었다.Purification was performed using a silica gel column chromatography method (toluene: methyl ethyl ketone) to obtain 1.1 g of 2-hydroxy4- (2-hydroxyethoxy) benzophenone.
계속해서 이것을 100㎎, 톨루엔 1㎖로 용해하고 아세틸말토스 219㎎, 몰리브드인산 10g을 가한후 100℃에서 30분간 가열교반했다.Subsequently, 100 mg and 1 ml of toluene were dissolved, 219 mg of acetylmaltose and 10 g of molybdenum phosphate were added, followed by heating and stirring at 100 ° C. for 30 minutes.
반응계를 실온까지 공냉한 후 톨루엔으로 추출하고 정제수로 1회, 포화식 염수로 4회수세한 후 유기층을 무수황산 마그네슘으로 건조하고 감압농축했다.The reaction system was cooled to room temperature, extracted with toluene, washed once with purified water and washed four times with saturated brine, and then the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure.
잔류물을 실리카겔칼럼크로마트그래피법(헥산 : 초산에틸)로 정제하고 2-히드록시 4-(2-말토실옥시에톡시) 벤조페논의 아세틸화물 110㎎을 얻었다.The residue was purified by silica gel column chromatography (hexane: ethyl acetate) to obtain 110 mg of an acetylate of 2-hydroxy 4- (2-maltosyloxyethoxy) benzophenone.
이 2-히드록시 4-(2-말토실옥시벤조페논)이 아세틸화물 100㎎을 메탄올 2㎖에 용해해서 나트륨메틸레이트 0.3㎖를 가해 실온에서 30분간 교반한후 이온교환수지(예를 들면 오르가노공업제의 안바라이트 IR 120B와 미쯔비시화성제의 UBK 530)로 중화후 수지를 여과후 제거하고 반응액을 감압농축해서 2-히드록시4-(2-말토실옥시에톡시)벤조페논을 얻었다.This 2-hydroxy 4- (2-maltosyloxybenzophenone) dissolves 100 mg of an acetylide in 2 ml of methanol, adds 0.3 ml of sodium methylate and stirs at room temperature for 30 minutes, followed by ion exchange resin (e.g. After neutralization with Anbarite IR 120B manufactured by Kano Industrial Co., Ltd. and UBK 530 manufactured by Mitsubishi Chemical, the resin was filtered off and the reaction solution was concentrated under reduced pressure to obtain 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone. .
수량은 80㎎이였다.The yield was 80 mg.
얻어진 2-히드록시 4-(2-말토실옥시에톡시)벤조페논을 다음의 (1)∼(6)의 방법에 의해 분석했다.The obtained 2-hydroxy 4- (2-maltosyloxyethoxy) benzophenone was analyzed by the method of following (1)-(6).
이렇게 해서 얻은 2-히드록시4-(2-말토실옥시에톡시)벤조페논을 시료1로 했다.Thus obtained 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone was used as sample 1.
(1) 적외흡수스펙트럼측정법(1) Infrared absorption spectrum measurement method
일본분광 주식회사제 IRA-1 적외흡수스펙트럼 측정장치를 사용하고 KBr 정제법으로 측정한 결과 3400㎝-1에 수산기의 신축진동, 2920㎝-1에 2-말토실옥시에톡시기의 신축진동, 1630㎝-1에 카로보닐기의 신축운동에서 흡수가 관측되었다.KBR Purification Method using IRA-1 Infrared Absorption Spectrometer manufactured by Nippon Spectroscopy Co., Ltd. as a result of stretching vibration of hydroxyl group at 3400cm -1 , stretching vibration of 2-maltosyloxyethoxy group at 2920cm -1 , 1630 Absorption was observed in the stretching motion of the carbonyl group at cm −1 .
(2)13C-NMR측정법(2) 13 C-NMR Measurement
일본전자 수기회사제의 JOEL GX-400에 의해 CD3OD를 용매로서 실온에서 측정한 결과.As a result of measuring at room temperature the CD 3 OD as solvent by Japan JOEL GX-400 of the electronic handwritten companies claim.
δ201ppm, 167ppm, 167ppm, 140ppm, 136ppm, 133ppm, 130ppm, 129ppm, 115ppm, 108ppm, 105ppm, 103ppm, 103ppm, 81ppm, 78ppm, 77ppm, 75ppm, 75ppm, 75ppm, 74ppm, 74ppm, 72ppm, 69ppm, 69ppm, 63ppm, 62ppm에 시그날이 관측되었다.δ 201ppm, 167ppm, 167ppm, 140ppm, 136ppm, 133ppm, 130ppm, 129ppm, 115ppm, 108ppm, 105ppm, 103ppm, 103ppm, 81ppm, 78ppm, 77ppm, 75ppm, 75ppm, 75ppm, 74ppm, 74ppm, 72ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm, 69ppm A signal was observed at 62 ppm.
결과를 제10도에 나타냈다.The results are shown in FIG.
(3)1H-NMR측정법(3) 1 H-NMR measurement
일본전자 주식회사제의 JOEL GW-400에 의해 CD3OD를 용매로서 실온에서 측정한 결과 δ7.53∼7.38, 6.46∼6.39, 4.72∼3.11에 시그날이 관측 되었다.As a result of measuring CD 3 OD as a solvent at room temperature by JOEL GW-400 manufactured by Nippon Electronics Co., Ltd., signals were observed at δ 7.53 to 7.38, 6.46 to 6.39, and 4.72 to 3.11.
결과를 제11도에 나타냈다.The results are shown in FIG.
(4) 자외선흡수스펙트럼측정법(4) UV absorption spectrum measurement method
구찌모토분광 주식회사 UVIDEC 610 자외흡수스펙트럼 측정장치를 사용하고 용매메탄올로 측정한 결과 287.6㎚, 324.6㎚에 극대흡수를 나타냈다.Using the UVIDEC 610 ultraviolet absorption spectrum measurement apparatus of Guccimoto Spectroscopy Co., Ltd., the maximum absorption was obtained at 287.6 nm and 324.6 nm using solvent methanol.
결과를 제12도에 나타냈다.The results are shown in FIG.
(5) 용점측정법(5) Melting point measuring method
ARTHUR H. THOMS COMPANY제 캐필라리식 융점측정장치를 사용해서 측정한 결과 92∼110℃로 용해했지만 명확한 융점을 나타내지 않았다.As a result of using a capillary melting point measuring apparatus manufactured by ARTHUR H. THOMS COMPANY, it was dissolved at 92 to 110 ° C, but no clear melting point was shown.
(6) 수용성(6) water soluble
물에 20중량 %이상 용해했다.It was dissolved in water at least 20% by weight.
[실시예 5]Example 5
2-히드록시4-(2-글루코실옥시에톡시)벤조페논2-hydroxy4- (2-glucosyloxyethoxy) benzophenone
실시예4로 합성한 2-히드록시4-(2-히드록시에톡시)벤조페논 100㎎을 톨루엔 2㎖로 용해하고 아세틸글루코스 136㎎을 가한후 100℃까지 승온해서 몰리브드인산 50㎎을 가한후 톨루엔으로 추출하고 정제수로 1회, 포화식염수로 4회 수세한 후 유기층을 무수황산 마그네슘으로 건조해서 감압농축했다.100 mg of 2-hydroxy4- (2-hydroxyethoxy) benzophenone synthesized in Example 4 was dissolved in 2 ml of toluene, 136 mg of acetylglucose was added, and the temperature was raised to 100 ° C. to obtain 50 mg of molybdate phosphate. After addition, the mixture was extracted with toluene, washed once with purified water and washed four times with saturated brine, and then the organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure.
잔류물을 실리카겔칼럼크로마트그래피법(헥산 : 초산에테르)으로 정제하고 2-히드록시4-(2-글루코실옥시에톡시)벤조페논의 아세틸화물을 189㎎얻었다.The residue was purified by silica gel column chromatography (hexane: ether acetate) to obtain 189 mg of acetylate of 2-hydroxy4- (2-glucosyloxyethoxy) benzophenone.
얻어진 2-히드록시4-(2-말토실옥시에톡시)벤조페논의 아세틸화물 189㎎을 메탄올 6㎖로 용해하고 나트륨메틸레이트 0.6㎖를 가해 실온에서 30분 교반한 후 이온교환수지(예를들면 오르가노공업제의 암바라이트 1R 120B과 미쯔비시화성제의 UBK 530)로 중화후 수지를 여과해 제거하고 반응액을 감압농축해서 2-히드록시4-(2-글루코실옥시에톡시)벤조페놀을 얻었다. 얻어진 2-히드록시나-C2-글리코실록시에톡시)벤조페논은 다음의 (1)∼(6) 방법에 의해 분석했다.Dissolve 189 mg of the obtained acetylate of 2-hydroxy4- (2-maltosyloxyethoxy) benzophenone in 6 ml of methanol, add 0.6 ml of sodium methylate, and stir for 30 minutes at room temperature, For example, after neutralizing with ambolite 1R 120B manufactured by organo industry and UBK 530 manufactured by Mitsubishi Chemical, the resin was filtered off and the reaction solution was concentrated under reduced pressure to produce 2-hydroxy4- (2-glucosyloxyethoxy) benzophenol. Got. The obtained 2-hydroxy and -C2-glycosyloxyethoxy) benzophenone was analyzed by the following (1)-(6) method.
(1) 적외흡수스펙트럼측정법(1) Infrared absorption spectrum measurement method
일본분광 주식회사제 IRA-1 적외흡수스펙트럼 측정장치를 사용하고 KBr 정제법으로 측정한 결과 3400㎝-1에 수산기의 신축진동, 2920㎝-1에 2-글루코실옥시에톡시기의 신축진동, 1630㎝-1에 카르보닐기의 신축운동에서 흡수가 관측되었다.KBR Purification Method using IRA-1 Infrared Absorption Spectrometer manufactured by Nippon Spectroscopy Co., Ltd. as a result of stretching vibration of hydroxyl group at 3400cm -1 , stretching vibration of 2-glucosyloxyethoxy group at 2920cm -1 , 1630 Absorption was observed in the stretching motion of the carbonyl group at cm −1 .
(2)13C-NMR측정법(2) 13 C-NMR Measurement
일본전자 수기회사제의 JOEL GX-400에 의해 CD3OD를 용매로서 실온에서 측정한 결과.As a result of measuring at room temperature the CD 3 OD as solvent by Japan JOEL GX-400 of the electronic handwritten companies claim.
δ201ppm, 167ppm, 167ppm, 140ppm, 136ppm, 133ppm, 130ppm, 129ppm, 114ppm, 109ppm, 108ppm, 104ppm, 103ppm, 78ppm, 75ppm, 72ppm, 69ppm, 69ppm, 62ppm에 시그날이 관측되었다.Signals were observed at δ 201 ppm, 167 ppm, 167 ppm, 140 ppm, 136 ppm, 133 ppm, 130 ppm, 129 ppm, 114 ppm, 109 ppm, 108 ppm, 104 ppm, 103 ppm, 78 ppm, 75 ppm, 72 ppm, 69 ppm, 69 ppm, 62 ppm.
결과를 제14도에 나타냈다.The results are shown in FIG.
(3)1H-NMR측정법(3) 1 H-NMR measurement
일본전자 주식회사제의 JOEL GX-400에 의해 CD3OD를 용매로서 실온에서 측정한 결과 δ7.53∼7.38, 6.46∼6.39, 4.28∼3.10에 시그날이 관측되었다.As a result of measuring CD 3 OD at room temperature with JOEL GX-400 manufactured by Nippon Electronics Co., Ltd., signals were observed at δ 7.53 to 7.38, 6.46 to 6.39, and 4.28 to 3.10.
결과를 제15도에 나타냈다.The results are shown in FIG.
(4) 자외선흡수스펙트럼측정법(4) UV absorption spectrum measurement method
구찌모토분광 주식회사 UVIDEC 610 자외흡수스펙트럼 측정장치를 사용하고 용매메탄올로 측정한 결과 286.9㎚, 324.3㎚에 극대흡수를 나타냈다.Using the UVIDEC 610 ultraviolet absorption spectrum measurement apparatus of Guccimoto Spectroscopy Co., Ltd., the maximum absorption was obtained at 286.9 nm and 324.3 nm using solvent methanol.
결과를 제16도에 나타냈다.The results are shown in FIG.
(5) 용점측정법(5) Melting point measuring method
화합물의 흡습성이 높고 측정할 수 없었다.The hygroscopicity of the compound was high and could not be measured.
(6) 용해성(6) solubility
물로 10중량%정도 용해했다.About 10% by weight was dissolved in water.
[실시예 6]Example 6
2-히드록시4-(3-말토실옥시프로필옥시)벤조페논2-hydroxy4- (3-maltosyloxypropyloxy) benzophenone
2,4-디히드록시벤조페논 1g을, 1-부로모프로판을 7.78g, 수산화나트륨 40㎎, 정제수 0.1㎖를 가해 용해했다.1 g of 2,4-dihydroxybenzophenone was added, and 7.78 g of 1-buromopropane, 40 mg of sodium hydroxide, and 0.1 ml of purified water were dissolved.
100℃까지 가열교반한 후 90℃로 내리고 다시 수산화나트륨 220㎎을 첨가했다.After stirring and heating to 100 ° C., the temperature was lowered to 90 ° C. and 220 mg of sodium hydroxide was added again.
4시간 가열교반한 후 공냉해서 글로로포름으로 추출, 수세후 건조·농축했다.After heating and stirring for 4 hours, the mixture was cooled with air, extracted with glow, dried with water, and concentrated.
실리카겔칼럼크로마토그래피법(톨루엔 : 메틸에틸케톤)를 사용해서 정제하고 2-히드록시4-(3-히드록시프로필옥시)벤조페논을 1.01g(수율80%)를 얻었다.Purification was carried out using a silica gel column chromatography method (toluene: methyl ethyl ketone) to obtain 1.01 g (yield 80%) of 2-hydroxy4- (3-hydroxypropyloxy) benzophenone.
얻어진 2-히드록시4-(3-히드록시프로필옥시)벤조페논 460㎎으로 옥타아세틸말토스 1.14g을 가해 톨루엔 10㎖로 용해하고 90℃로 승온한 후 몰리브드인산을 촉매량 첨가했다.Octaacetyl maltose 1.14g was added to 460 mg of obtained 2-hydroxy4- (3-hydroxypropyloxy) benzophenone, and it melt | dissolved in 10 ml of toluene, heated up at 90 degreeC, and the catalytic amount of molybdate phosphoric acid was added.
30분간 가열교반한 후 공냉해서 톨루엔 100㎖로 추출하고 포화중조수로 세정했다.After heating and stirring for 30 minutes, the mixture was air cooled, extracted with 100 ml of toluene, and washed with saturated sodium bicarbonate water.
건조·농축한 후 실리카겔칼럼크로마트그래피법(톨루엔 : 메틸에틸케톤)으로 정제하고 2-히드록시4-(3-말토실옥시프로필옥시)벤조페논의 아세틸화물을 880㎎(수율 60%)를 얻었다.After drying and concentrating, the product was purified by silica gel column chromatography (toluene: methyl ethyl ketone) to obtain 880 mg (yield 60%) of acetylate of 2-hydroxy4- (3-maltosyloxypropyloxy) benzophenone. Got it.
얻어진 2-히드록시4-(3-말토실옥시프로필옥시)벤조페논의 아세틸화물 880㎎을 메탄올 20㎖로 용해하고 나트륨메톡사이드를 가해 30분간 교반한 후 산성수지로 중화하고 여과후 농축해서 2-히드록시4-(3-말토실옥시프로필옥시)벤조페논 565㎎(수율 100%)를 얻었다.Dissolve 880 mg of the obtained acetylate of 2-hydroxy4- (3-maltosyloxypropyloxy) benzophenone in 20 ml of methanol, add sodium methoxide, stir for 30 minutes, neutralize with acidic resin, concentrate after filtration and concentrate. 565 mg (yield 100%) of -hydroxy4- (3-maltosyloxypropyloxy) benzophenone was obtained.
얻어진 2-히드록시4-(3-말토실옥시프로필옥시)벤조페논을 다음의 (1)∼(6)방법에 의해 확인했다.Obtained 2-hydroxy4- (3-maltosyloxypropyloxy) benzophenone was confirmed by the following (1)-(6) method.
(1) 적외흡수스펙트럼측정법(1) Infrared absorption spectrum measurement method
일본분광 주식회사제 IRA-1 적외흡수스펙트럼 측정장치를 사용하고 KBr 정제법으로 측정한 결과 3400㎝-1에 수산기의 신축진동, 2920㎝-1에 3-말토실옥시기의 신축운동, 1630㎝-1에 카르보닐기의 신축운동에서 흡수가 관측되었다.Japan Spectroscopic Co., Ltd. using the IRA-1 infrared absorption spectrum measuring apparatus, and expansion and contraction of the 3-end of tosyl oxy group in the stretching vibration, 2920㎝ -1 of the hydroxyl group in the resulting 3400㎝ -1 measured by the KBr tablet method exercise, 1630㎝ - Absorption was observed in the stretching of the carbonyl group at 1 .
결과를 제17도에 나타냈다.The results are shown in FIG.
(2)13C-NMR측정법(2) 13 C-NMR Measurement
일본전자 수기회사제의 JOEL GX-400에 의해 CD3OD를 용매로서 실온에서 측정한 결과.As a result of measuring at room temperature the CD 3 OD as solvent by Japan JOEL GX-400 of the electronic handwritten companies claim.
δ201ppm, 167ppm, 167ppm, 140ppm, 136ppm, 133ppm, 130ppm, 129ppm, 114ppm, 109ppm, 104ppm, 103ppm, 81ppm, 78ppm, 76ppm, 75ppm, 75ppm, 74ppm, 71ppm, 67ppm, 67ppm, 63ppm, 62ppm, 30ppm에 시그날이 관측되었다.δ201ppm, 167ppm, 167ppm, 140ppm, 136ppm, 133ppm, 130ppm, 129ppm, 114ppm, 109ppm, 104ppm, 103ppm, 81ppm, 78ppm, 76ppm, 75ppm, 75ppm, 74ppm, 71ppm, 67ppm, 67ppm, 63ppm, 62ppm, 62ppm, 62ppm Observed.
결과를 제18도에 나타냈다.The results are shown in FIG.
(3)1H-NMR측정법(3) 1 H-NMR measurement
일본전자 주식회사제의 JOEL GX-400에 의해 CDOD를 용매로서 실온에서 측정한 결과 δ7.55ppm, 7.50ppm, 7.43ppm, 6.56ppm, 6.50ppm, 6.44ppm, 5.22ppm∼1.9ppm에 시그날 관측되었다.As a result of measuring CDOD as a solvent at room temperature by JOEL GX-400 manufactured by Nippon Electronics Co., Ltd., signals were observed at δ 7.55 ppm, 7.50 ppm, 7.43 ppm, 6.56 ppm, 6.50 ppm, 6.44 ppm, and 5.22 ppm to 1.9 ppm.
결과를 제19도에 나타냈다.The results are shown in FIG.
(4) 자외선흡수스펙트럼측정법(4) UV absorption spectrum measurement method
구찌모토분광 주식회사 UVIDEC 610 자외흡수스펙트럼 측정장치를 사용하고 용매메탄올로 측정한 결과 289.4㎚, 324.1㎚에 극대흡수를 나타냈다.Using the UVIDEC 610 ultraviolet absorption spectrum measuring apparatus of Guccimoto Spectroscopy Co., Ltd., the maximum absorption was obtained at 289.4 nm and 324.1 nm using solvent methanol.
결과를 제20도에 나타냈다.The results are shown in FIG.
(5) 용점측정법(5) Melting point measuring method
ARTHUR H. THOMS COMPANY제 캐필라리식융점측정장치를 사용해서 측정한바 77∼87℃로 용해했지만 명확한 융점을 나타내지 않았다.It was measured using a capillary melting point measuring apparatus manufactured by ARTHUR H. THOMS COMPANY, and was dissolved at 77 to 87 ° C, but no clear melting point was shown.
(6) 용해성(6) solubility
물에 20중량%이상 용해했다.It was dissolved in water at least 20% by weight.
[실험예 4]Experimental Example 4
미용액의 제조Preparation of Serum
표4과 같은 처방으로 벤조페논유도체를 배합한 미용액과 대조예로서 2-히드록시-4-메톡시-5-설폭소늄벤조페놀을 배합한 미용액의 제조를 실시했다.The cosmetic liquid which mix | blended the benzophenone derivative with the benzophenone derivative | guide_body, and the cosmetic liquid which mix | blended 2-hydroxy-4-methoxy-5-suloxonium benzophenol as a control example were produced by the prescription shown in Table 4.
[표 4]TABLE 4
알콜상A를 수상B에 첨가해서 향료를 가용화해서 미용액을 얻었다.Alcohol phase A was added to the water phase B to solubilize the perfume to obtain a cosmetic liquid.
배합예2은 무색투명하고 점성이 있는 양호한 미용액을 얻을 수 있는 것에 대해 대조예2은 황색기미가 강하고 점성이 없는 것이였다.The compounding example 2 was a colorless, transparent and viscous good cosmetic liquid, whereas the comparative example 2 had strong yellowish tinge and no viscosity.
[시험예 5][Test Example 5]
자외선(햇빛)차단테스트UV light blocking test
시험예4에서 제조한 2개의 미용액을 사용해서 해변에서 직접사용해 테스트 했다.Two cosmetic liquids prepared in Test Example 4 were used and tested directly on the beach.
방법으로서는 샘플을 남녀 각 20명의 배에 좌우반씩 도포하고 햇빛에 탄정도를 판정했다.As a method, the sample was apply | coated to the tummy of 20 men and women, and the degree of sunburn was determined.
판정기준은 하기와 같이 했다.Judgment criteria were as follows.
햇빛에 탄 정도의 평가기준등을 상기 시험예2에 의한다.Evaluation criteria of the degree of sunburn are the same as in Test Example 2 above.
결과를 표5에 나타낸다.The results are shown in Table 5.
[표 5]TABLE 5
이들의 결과로부터 벤조페놀유도체를 배합한 피부외용제는 종래의 수용성 자외선흡수제를 배합한 피부외용제보다도 자외선방어효과가 높고 피부트러블도 없어 안전성이 높은 것이었다.From these results, the skin external preparation containing the benzophenol derivative was higher in UV protection effect and safer than the skin external preparation incorporating the conventional water-soluble ultraviolet absorbent.
[시험예 6][Test Example 6]
보습성Moisturizing
상기 시험예3에 의거 보습성을 조사했다.The moisture retention was investigated based on the said Test Example 3.
결과를 표6에 나타낸다.The results are shown in Table 6.
[표 6]TABLE 6
이상의 결과로부터, 본 발명에 관련된 벤조페논유도체를 배합한 피부외용제는 종래는 수용성자외선흡수제를 배합한 피부외용제보다 보습성이 높은 우수한 것이라는 것을 알았다.From the above results, it has been found that the external skin preparations incorporating the benzophenone derivative according to the present invention have superior moisturizing properties than the external skin preparations incorporating a water-soluble ultraviolet absorbent.
이하 본 발명에 관한 피부외용제의 배합예를 설명한 바, 각 피부외용제로 우수한 자외선 방어효과를 나타낸다.Hereinafter, a combination example of the external preparation for skin according to the present invention will be described. Each of the external preparation for skin exhibits excellent ultraviolet protective effect.
[실시예 7]Example 7
크림cream
A. 유지A. Maintenance
스테아린산 10.0Stearic Acid 10.0
스테아린알콜 4.0Stearin Alcohol 4.0
스테아린산 모노글리세린에스테르 8.0Stearic Acid Monoglycerin Ester 8.0
비타민E 아세테이트 0.5Vitamin E Acetate 0.5
향료 0.4Spices 0.4
에틸파라벤 0.1Ethylparaben 0.1
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
프로필렌글리콜 8.0Propylene Glycol 8.0
글리세린 2.0Glycerin 2.0
1-(4-벤조일-3-히드록시페닐)글리세롤멀티톨루에테르 6.01- (4-benzoyl-3-hydroxyphenyl) glycerol multitoluether 6.0
수산화칼륨 0.4Potassium Hydroxide 0.4
에테트산이나트륨 0.05Disodium Ethate 0.05
정제수 잔부Purified water balance
제법quite
A의 유상부와 B의 수상부를 각각 70℃로 가열해서 완전용해한다.The oil phase part of A and the water phase part of B are respectively heated to 70 ° C. and completely dissolved.
A상을 B상에 가해 유화기로 유하한다.Phase A is added to phase B and flows down into the emulsifier.
유화물을 열교환기를 사용해 냉각하고 크림을 얻었다.The emulsion was cooled using a heat exchanger to obtain a cream.
[실시예 8]Example 8
크림cream
A. 유상A. Paid
세탄올 4.0Cetanol 4.0
바세린 7.0Vaseline 7.0
이소프로필미리스테이트 8.0Isopropyl myristate 8.0
스쿠알렌 12.0Squalane 12.0
디메틸폴리실록산 3.0Dimethylpolysiloxane 3.0
스테아린산모노글리세린에스테르 2.2Stearic Acid Monoglycerin Ester 2.2
POE(20)솔비탄모노스테아레이트 0.5POE (20) sorbitan monostearate 0.5
글리실리틴산스테아레이트 0.1Glycylinic Acid Stearate 0.1
BHT 0.02BHT 0.02
에틸파라벤 0.1Ethylparaben 0.1
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
1,3부틸렌글리콜 7.01,2-butylene glycol 7.0
에테트산이나트륨 0.07Disodium Ethate 0.07
펜옥시에탄올 0.2Phenoxyethanol 0.2
L-아스콜빈산인산에스테르마그네슘염 3.0L-ascorbic acid phosphate ester magnesium salt 3.0
폴리아크릴산알킬에스테르 1.0Polyacrylic acid alkyl ester 1.0
1-(4-벤조일페닐)글리세롤멀티톨루에테르 8.01- (4-benzoylphenyl) glycerol multitoluether 8.0
정제수 잔부Purified water balance
제법quite
실시예7에 의거 크림을 얻었다.A cream was obtained according to Example 7.
[실시예 9]Example 9
유액latex
A. 유상A. Paid
올레일올레이트 3.0Oleyl oleate 3.0
바셀린 7.0Vaseline 7.0
스쿠알렌 5.0Squalene 5.0
솔비탄세스키올레인산에스테르 0.8Sorbanthose skioleate ester 0.8
폴리옥시에틸렌올레일에테르 1.2Polyoxyethylene Oleyl Ether 1.2
1-(4-벤조일-3-히드록시페닐)글리세롤솔베이트에테르 3.01- (4-benzoyl-3-hydroxyphenyl) glycerol sorbate ether 3.0
메틸파라벤 0.1Methylparaben 0.1
향료 0.12Spices 0.12
B. 수상B. Award
디프로필렌글리콜 5.0Dipropylene Glycol 5.0
에탄올 3.0Ethanol 3.0
카복시비닐폴리머 0.17Carboxy Vinyl Polymer 0.17
히알로닉산나트륨 0.01Sodium hyaluronate 0.01
폴리아크릴산알킬에스테르 1.0Polyacrylic acid alkyl ester 1.0
1-(4-벤조일-3-히드록시페닐)글리세롤슈거에테르 4.01- (4-benzoyl-3-hydroxyphenyl) glycerolsugar ether 4.0
수산화칼륨 0.08Potassium Hydroxide 0.08
헥사메타인산나트륨 0.05Sodium hexametaphosphate 0.05
정제수 잔부Purified water balance
제법quite
실시예7에 의해 유액을 얻었다.The emulsion was obtained in Example 7.
[실시예 10]Example 10
크림cream
A. 유상A. Paid
베헤닐알콜 0.5Behenyl Alcohol 0.5
12-히드록시스테아린산콜레스탄올에스테르 2.012-hydroxystearic acid cholestanol ester 2.0
스쿠알렌 7.0Squalene 7.0
호호바오일 5.0Jojoba Oil 5.0
자기유화형모노스테아린산글리세린 2.5Self-emulsifying monoglycerin glycerol 2.5
폴리옥시에틸렌솔비탄모노스테아린산에스테르 1.5Polyoxyethylene sorbitan monostearic acid ester 1.5
2-메톡시벤조페논 3.02-methoxybenzophenone 3.0
에틸파라벤 0.2Ethylparaben 0.2
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
프로필렌글리콜 5.0Propylene Glycol 5.0
에디트산산나트륨 0.08Sodium Editate 0.08
글리세린 5.0Glycerin 5.0
비캄(모노모리로나이트) 3.0Bicam (monomori low knight) 3.0
수산화칼륨 0.3Potassium Hydroxide 0.3
1-(4-벤조일-3-히드록시페닐)글리세롤마르토트리올에테르 8.01- (4-benzoyl-3-hydroxyphenyl) glycerolmartotriolether 8.0
정제수 잔부Purified water balance
제법quite
실시예7에 의해 크림을 얻었다.The cream was obtained by Example 7.
[실시예 11]Example 11
분말입화장수Powder
A. 유상A. Paid
에탄올 8.0Ethanol 8.0
POE(60)글리세릴모노이소스테아레이트 2.0POE (60) glyceryl Monoisostearate 2.0
L-멘톨 0.1L-menthol 0.1
캄파 0.1Campa 0.1
메틸파라벤 0.2Methylparaben 0.2
향료 정량Fragrance quantification
B. 수상B. Award
글리세린 3.5Glycerin 3.5
1-(4-벤조일페닐)글리세롤마르토트리올에테르 4.01- (4-benzoylphenyl) glycerolmartotriolether 4.0
아연 1.5Zinc 1.5
카올린 0.5Kaolin 0.5
벤토나이트 0.3Bentonite 0.3
헥사메타인산나트륨 0.03Sodium hexametaphosphate 0.03
정제수 잔부Purified water balance
제법quite
실시예7에 의해 화장수를 얻었다.A lotion was obtained in Example 7.
[실시예 12]Example 12
크림cream
A. 유지A. Maintenance
스테아린산 10.0Stearic Acid 10.0
스테아릴알콜 4.0Stearyl Alcohol 4.0
스테아린산모노글리세린에스테르 8.0Stearic Acid Monoglycerin Ester 8.0
비타민E 아세테이트 0.5Vitamin E Acetate 0.5
향료 0.4Spices 0.4
에틸파라벤 0.1Ethylparaben 0.1
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
프로필렌글리콜 8.0Propylene Glycol 8.0
글리세린 2.0Glycerin 2.0
2-히드록시-4-(2-말토실옥시에톡시)벤조페논 8.02-hydroxy-4- (2-maltosyloxyethoxy) benzophenone 8.0
수산화칼륨 0.4Potassium Hydroxide 0.4
에데트산삼나트륨 0.05Trisodium Edetate 0.05
정제수 잔부Purified water balance
제법quite
실시예7에 의해 크림을 얻었다.The cream was obtained by Example 7.
[실시예 13]Example 13
크림cream
A. 유상A. Paid
세탄올 4.0Cetanol 4.0
와세린 7.0Waserine 7.0
이소프로필미리스테이트 8.0Isopropyl myristate 8.0
스쿠알렌 12.0Squalane 12.0
디메틸폴리실록산 3.0Dimethylpolysiloxane 3.0
스테아린산모노글리세린에스테르 2.2Stearic Acid Monoglycerin Ester 2.2
POE(20)솔비탄모노스테아레이트 0.5POE (20) sorbitan monostearate 0.5
글리틸레틴산스테아레이트 0.1Glytile-Stearate 0.1
BHT 0.02BHT 0.02
에틸파라벤 0.1Ethylparaben 0.1
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
1,3부틸렌글리콜 7.01,2-butylene glycol 7.0
에데트산이나트륨 0.07Disodium Edetate 0.07
페녹시에탄올 0.2Phenoxyethanol 0.2
아스코르빈산인산에스테르마그네슘염 3.0Ascorbic acid phosphate ester magnesium salt 3.0
폴리아크릴산알킬에스테르 1.0Polyacrylic acid alkyl ester 1.0
2-히드록시-4-(2-글리세로일에톡시)벤조페논 8.02-hydroxy-4- (2-glyceroylethoxy) benzophenone 8.0
정제수 잔부Purified water balance
제법quite
실시예7에 의해 크림을 얻었다.The cream was obtained by Example 7.
[실시예 14]Example 14
유액latex
A. 유상A. Paid
올레일올레리트 3.0Ole Oleit 3.0
바세린 7.0Vaseline 7.0
스쿠알렌 5.0Squalene 5.0
솔비탄세스키올레인산에스테르 0.8Sorbanthose skioleate ester 0.8
폴리옥시에틸렌올레일에테르(20E. 0.) 1.2Polyoxyethylene Oleyl Ether (20E.0.) 1.2
디 p-메톡시계피산글리세린 3.0Di p-methoxy cinnamic acid glycerin 3.0
메틸파라벤 0.1Methylparaben 0.1
향료 0.12Spices 0.12
B. 수상B. Award
디프로필렌글리콜 5.0Dipropylene Glycol 5.0
에탄올 3.0Ethanol 3.0
카르복시비닐폴리머 0.17Carboxy Vinyl Polymer 0.17
히알론산나트륨 0.01Sodium Hyaluronate 0.01
폴리아크릴산알킬에스테르 1.0Polyacrylic acid alkyl ester 1.0
2,2′-디히드록시4-(2-말토실옥시에톡시)벤조페논 4.02,2'-dihydroxy4- (2-maltosyloxyethoxy) benzophenone 4.0
수산화칼륨 0.08Potassium Hydroxide 0.08
헥사메타인산나트륨 0.05Sodium hexametaphosphate 0.05
정제수 잔부Purified water balance
제법quite
실시예7에 의해 유액을 얻었다.]The emulsion was obtained in Example 7.]
[실시예 15]Example 15
크림cream
A. 유상A. Paid
베헤닐알콜 0.5Behenyl Alcohol 0.5
12-히드록시스테아린산콜레스탄올에스테르 2.012-hydroxystearic acid cholestanol ester 2.0
스쿠알렌 7.0Squalene 7.0
호호바오일 5.0Jojoba Oil 5.0
자기유화형모노스테아린산글리세린 2.5Self-emulsifying monoglycerin glycerol 2.5
폴리옥시에틸렌솔비탄모노스테아린산에스테르(20E0) 1.5Polyoxyethylene sorbitan monostearic acid ester (20E0) 1.5
2-히드록시-4-메톡시벤조페논 3.02-hydroxy-4-methoxybenzophenone 3.0
에틸파라벤 0.2Ethylparaben 0.2
부틸파라벤 0.1Butylparaben 0.1
프로필파라벤 0.1Propylparaben 0.1
B. 수상B. Award
프로필렌글리콜 5.0Propylene Glycol 5.0
에데트산산나트륨 0.08Sodium Edetate 0.08
글리세린 5.0Glycerin 5.0
(비캄)몬모리로나이트 3.0(Beckham) montmorillonite 3.0
수산화칼륨 0.3Potassium Hydroxide 0.3
2,2', 4' 트리히드록시-4-(2-마르토실록시에톡시)벤조페논 8.02,2 ', 4' trihydroxy-4- (2-martosiloxyethoxy) benzophenone 8.0
정제수 잔부Purified water balance
제법quite
실시예7에 의해 크림을 얻었다.The cream was obtained by Example 7.
[실시예 16]Example 16
분말입(入)화장수Powdered Cosmetics
A. 유상A. Paid
에탄올 8.0Ethanol 8.0
POE(60)글리세릴모노이소스테아레이트 2.0POE (60) glyceryl Monoisostearate 2.0
L-멘톨 0.1L-menthol 0.1
캄파 0.1Campa 0.1
메틸파라벤 0.2Methylparaben 0.2
향료 적량Spices
B. 수상B. Award
글리세린 3.5Glycerin 3.5
2-히드록시-4(3-말토실록시부톡시)벤조페논 4.02-hydroxy-4 (3-maltosiloxybutoxy) benzophenone 4.0
아연 1.5Zinc 1.5
카올린 0.5Kaolin 0.5
벤토나이트 0.3Bentonite 0.3
헥사메탈인산나트륨 0.03Hexametal sodium phosphate 0.03
정제수 잔부Purified water balance
제법quite
실시예7에 의해 화장수를 얻었다.A lotion was obtained in Example 7.
이상 설명한 바와 같이 본 발명에 관련된 벤조페논유도체에 의하면 우수한 자외선흡수능력 및 극성용매상용성을 가진다.As described above, the benzophenone derivative according to the present invention has excellent ultraviolet absorbing ability and polar solvent compatibility.
또한 이것을 배합한 피부외용제는 극성기제에 대해서도 배합가능하고 우수한 사용성을 발휘함을 알았다.In addition, it has been found that the external skin preparation blended with the same can be blended with the polar base and exhibits excellent usability.
Claims (11)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP91-301076 | 1991-10-21 | ||
JP30107691A JP3207471B2 (en) | 1991-10-21 | 1991-10-21 | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same |
JP26296292A JP3140575B2 (en) | 1992-09-04 | 1992-09-04 | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same |
JP92-262962 | 1992-09-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR930007884A KR930007884A (en) | 1993-05-20 |
KR100226142B1 true KR100226142B1 (en) | 1999-10-15 |
Family
ID=26545791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920019299A Expired - Fee Related KR100226142B1 (en) | 1991-10-21 | 1992-10-20 | Benzophenone derivatives, UV absorbers and external skin preparations containing them |
Country Status (4)
Country | Link |
---|---|
US (1) | US5342610A (en) |
EP (1) | EP0538839B1 (en) |
KR (1) | KR100226142B1 (en) |
DE (1) | DE69231656T2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5741905A (en) * | 1994-07-23 | 1998-04-21 | Ciba Specialty Chemicals Corporation | Triazine ultraviolet absorbers useful for improving the sun protection factor of textiles |
US5665804A (en) * | 1996-02-05 | 1997-09-09 | Dow Corning Corporation | Silicone latex solvent thickening |
KR19980054323A (en) * | 1996-12-27 | 1998-09-25 | 성재갑 | Polymer compound containing a benzophenone derivative, its manufacturing method, and the sunscreen composition containing the compound |
US6059991A (en) | 1997-12-12 | 2000-05-09 | Troy Technology Corporation, Inc. | Stabilized composition containing halopropynyl compounds |
US6034003A (en) * | 1997-12-29 | 2000-03-07 | Lee; Kui-Fong | Ultraviolet radiation protective clothing |
US5938825A (en) * | 1998-05-21 | 1999-08-17 | Troy Technology Corporation Inc. | Stabilized antimicrobial compositions containing halopropynyl compounds |
US6472424B1 (en) | 2000-06-07 | 2002-10-29 | Troy Technology Corporation, Inc. | Stabilized antimicrobial compositions containing halopropynyl compounds and benzylidene camphors |
KR20060013467A (en) | 2003-05-22 | 2006-02-10 | 어피니티컴퍼니,리미티드 | Autonomous light control laminated body and window using the same |
EP1630600A3 (en) * | 2004-07-29 | 2006-03-22 | Rohm and Haas Electronic Materials, L.L.C. | Hot melt composition and method involving forming a masking pattern |
CN112795282A (en) * | 2020-12-30 | 2021-05-14 | 万博新材料科技(南通)有限公司 | A kind of synthetic method of ultraviolet absorber for water-based coil topcoat |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH475214A (en) * | 1965-06-04 | 1969-07-15 | Ciba Geigy | Process for the preparation of sulfonic acid or sulfonate-containing hydroxybenzophenones |
US3676471A (en) * | 1967-12-21 | 1972-07-11 | Advance Prod Gmbh | 4-(betahydroxyethoxy-2-hydroxy-benzophenones) and esters thereof |
FR2307820A1 (en) * | 1975-04-17 | 1976-11-12 | Hayashibara Seibutsu Chem Inst | ECHINATINE GLYCOSIDES AND THEIR PREPARATION |
JPS58110535A (en) * | 1981-12-25 | 1983-07-01 | Pola Chem Ind Inc | Novel benzophenone derivative and ultraviolet absorber |
-
1992
- 1992-10-20 US US07/963,901 patent/US5342610A/en not_active Expired - Fee Related
- 1992-10-20 KR KR1019920019299A patent/KR100226142B1/en not_active Expired - Fee Related
- 1992-10-21 EP EP92118026A patent/EP0538839B1/en not_active Expired - Lifetime
- 1992-10-21 DE DE69231656T patent/DE69231656T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0538839A1 (en) | 1993-04-28 |
US5342610A (en) | 1994-08-30 |
EP0538839B1 (en) | 2001-01-24 |
KR930007884A (en) | 1993-05-20 |
DE69231656D1 (en) | 2001-03-01 |
DE69231656T2 (en) | 2001-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5426210A (en) | Adduct of cinnamic acid and glycerin, ultraviolet absorbent and external preparation for skin | |
KR100226142B1 (en) | Benzophenone derivatives, UV absorbers and external skin preparations containing them | |
KR20230121826A (en) | Method for producing 2-(4'-diethylamino-2'-hydroxybenzoyl)benzoic acid hexyl ester | |
JPH04134042A (en) | Styryl ketone derivative, ultraviolet absorber containing said derivative and cosmetic containing said absorber | |
JP3007171B2 (en) | Sugar-cinnamic acid derivatives and UV absorbers | |
JP3034057B2 (en) | Sugar-cinnamic acid derivatives and UV absorbers | |
JP2999829B2 (en) | External preparation for skin | |
JP3207471B2 (en) | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same | |
JP2999564B2 (en) | External preparation for skin | |
JP3144715B2 (en) | Styryl ketone derivative, ultraviolet absorber using the same, and external preparation for skin containing the same | |
JP3140575B2 (en) | Benzophenone derivative, ultraviolet absorber and external skin preparation containing the same | |
JP3534938B2 (en) | Hydantoin derivatives, ultraviolet absorbers and skin external preparations | |
JP2923358B2 (en) | Glycerin cinnamate adduct, UV absorber and external preparation for skin | |
JP3976816B2 (en) | Hydantoin derivatives, UV absorbers and skin external preparations | |
JPH08283286A (en) | Benzophenone derivative, ultraviolet light absorber and dermal preparation for external use blended with the same | |
JPH09255696A (en) | Benzophenone derivative, ultraviolet light absorbent and preparation containing the same and used for external use for skin | |
JP3534939B2 (en) | Cinnamic acid derivatives, UV absorbers and skin external preparations | |
JP3340930B2 (en) | Melanin production inhibitor and whitening cosmetic | |
JPH08127589A (en) | Glucohydantoin derivative, ultraviolet absorbent and skin preparation for external use | |
JP3485377B2 (en) | UV absorber | |
JPH09255545A (en) | Skin preparation for external use | |
JP3170386B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
JPH07242693A (en) | 1,3-propanedione derivative, ultraviolet light absorber and skin external preparation containing the same blended therein | |
JPH09268194A (en) | Cinnamic acid derivative, ultraviolet absorber and preparation for external use for skin | |
EP0632029A1 (en) | Benzylidene hydantoin derivative, ultraviolet ray absorbent and external preparation for skin including the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
A201 | Request for examination | ||
PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
FPAY | Annual fee payment |
Payment date: 20020525 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20030727 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20030727 |
|
R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |